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Abstract 
 
Organocatalysis using novel axially chiral secondary amines 
Keywords: Organocatalyst, Axial chirality, Aldol reaction, Mannich reaction, amino acid. 
 
The field of organocatalysis has grown rapidly in the last 20 years. Moreover it is a big challenge 
in modern chemistry due to the rewards that can be gained from its efficiency, low cost and low 
toxicity. In addition, organocatalysis has many advantages in industrial chemistry it can save time 
and money by avoiding the use of large amounts of solvents and thus minimizing waste.  
This Thesis is broken down into three chapters, the first one presents a review of organocatalysis 
including recent updates and developments, and introduces the different organocatalyst classes, 
their modes of activation, and a number of examples which show the selectivity improvements 
obtained. 
The second chapter is divided into two parts. The first part descries the synthesis of certain 
binaphthyl organocatalysts and a description of the key steps of their synthesis: a 
diastereoselective Reformatsky addition and asymmetric lithiation and 
chloroformate/carboxylation addition steps. The second part focuses on the applications and the 
results obtained when these catalysts were used in aldol and Mannich reactions. 
The third chapter contains the experimental data for the products that are discussed in chapter two. 
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Bu                               Butyl 
BuLi                            n-Butyllithium 
Cbz                              Carboxybenzyl 
°C                                Degrees Celsius 
cm-1                             Wavenumber 
d                                   Days 
DBU                            1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCM                           Dichloromethane 
DDQ                            2,3-dichloro-3,6-dicyano-1,4-benzoquinone 
DIBAL                        Diisobutylaluminium hydride 
DMAc                         Dimethylacetamide 
DMAP                         Dimethylaminopyridine 
DMF                            N,N-Dimethylforamide 
DMSO                         Dimethylsulfoxide 
dppe                             1,2-Bis(diphenylphosphino)ethane 
DppONH2                   O-(Diphenylphosphinyl)-hydroxylamine 
e.e                                Enantiomeric excess 
E+                                  Electrophile 
EDAC                          1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
equiv.                            Equivalents 
Et                                  Ethyl 
g                                   Grams 
h                                    Hour 
HOBT                           Hydroxybenzotriazole 
HOMO                          Highest occupied molecular orbital 
HPLC                            High performance liquid chromatography 
HRMS                           High resolution liquid chromatography 
iPr                                  Iso-propyl 
IR                                   Infrared 
IPA                                 Iso-propyl alcohol 
K                                     Kelvin scale 
LUMO                            Lowest unoccupied molecular orbital 
M                                    Molar 
m.p.                                 Melting point 
Me                                   Methyl 
v 
 
MHz                               MegaHertz 
min                                 Minute 
mL                                  Millilitre 
mmol                              Millimole 
NBS                               N-Bromosuccinimide 
NMR                              Nuclear Resonance Spectroscopy 
Nu−                                 Nucleophile 
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TFA                                  Trifluoroacetic acid 
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Chapter one: Introduction 
 
1.0 Asymmetric catalysis 
As the biological activities of many pharmaceutical compounds are related to their absolute 
configurations, the need to make chiral drugs in an enantiomerically pure form is growing 
rapidly. Before the 1980’s, drug synthesis generally provided racemic mixtures, which led to 
having two enantiomers, one was beneficial to use as a drug, while the second enantiomer could 
be inactive or even harmful. 1 Because of the possibility of harmful effects coming from one 
enantiomer, worldwide governments developed roles and regulations for drug companies 
which synthesise chiral drugs, such as, the Committee for Proprietary Medical Products (EU) 
demanding them to separate any chiral drug and evaluate their individual activity and toxicity.2 
Asymmetric catalysts could help to lower the pharmaceutical companies risk in terms of 
wasting money and time in synthesis and purification by affording a single enantiomer.  
 
1.1 Classes of asymmetric catalysis 
The classic methods for purifying and isolating a single pure enantiomer are: chiral auxiliary, 
kinetic resolution, resolution of the racemic mixture and chiral pool approach. However, these 
methods cannot be compared with asymmetric catalysis as it is considered the least wasteful. 
There are three main areas that asymmetric catalysis includes: organometallic catalysis, 
biocatalysis and organocatalysis. 
 
1.1.1 Organometallic catalysis  
Since the Nobel prize was awarded to Karl Ziegler, Giulio Natta, Geoffrey Wilkinson, and E. 
O. Fischer for their contributions in the area of science and technology specifically in 
organometallic chemistry, organometallic catalysis has become a powerful tool to increase 
production, such as high octane gasoline obtained by "cracking" of petroleum with 
organometallic catalysts, which was used during World War II by the Allied forces. On the 
other hand, Germany used diesel fuel which was synthesised using a metallic catalyst. In 
addition, the high demand for more highly pure chemicals led Ziegler and his co-workers to 
develop a catalyst to use in the synthesis of polyolefins.3 Furthermore, in 1968, Knowles had 
used and developed [Rh(R,R)-DiPAMP)COD]BF4 as catalyst for the first industrial 
asymmetric catalytic reaction to synthesise a rare amino acid (S)-DOPA 2 which is a chiral 
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drug used in the treatment of Parkinson’s disease , the catalyst was used in the synthesis of the 
drug for a hydrogenation step which afforded 1 in excellent e.e. (95%) and quantitative yield 
(Scheme 1).4  
 
 
In addition, Noyori has used Ru-BINAP 3 in drug synthesis, such as, the synthesis of Naproxen, 
an anti-inflammatory drug. The result was 92% yield and 97% enantiomeric excess. Moreover, 
Noyori has also applied his Ru-BINAP in the synthesis of an antibiotic called Levofloxacin 
(Scheme 2).5 
 
 
In 2001, Noyori, Knowles and Sharpless were awarded the Nobel Prize in chemistry. Sharpless 
won his share for his work on asymmetric oxidations. Sharpless focused his work on the 
formation of chiral epoxides and diols from carbon–carbon bonds. For example, by using a 
titanium (IV) catalyst with tert-butylhydroperoxide, allylic alcohols were converted into the 
respective epoxyalcohols.6 Sharpless selective methods have inspired Industry in the synthesis 
of stabilised enantio-enriched glycidol derivatives. Indeed, glycidyl 3-nitrobenzenesulfonate 
will generally be the substrate of choice for reactions requiring direct displacement of an 
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arenesulfonate moiety.7 Moreover, the Sharpless methodology has also been used to synthesise 
the key intermediate of several antibiotics, such as Methymycin, Erythromycin, and 
Leukotriene C-1 (Scheme 3).8 
 
 
However, despite its huge success, organometallic catalysis has some disadvantages, for 
example, most of the reactions that involve metallic catalysts require exacting reaction 
conditions such as the exclusion of air and moisture. Furthermore, the cost of the catalysts is 
very high and commonly they are toxic. 
 
1.1.2 Biocatalysis 
The use of enzymes or macromolecules such as proteins in asymmetric catalysis to produce a 
chemical transformation is called biocatalysis. In contrast to organometallic catalysis, 
biocatalysis is generally cleaner and safer because the solvent is often water. In addition, the 
use of biocatalysts in organic reactions can afford the product in high yield and high 
enantioselectivity. For more than 50 years, biocatalysts have been used in industrial production 
of enantiomerically pure amino acids and their derivatives that are used in the preparation of 
pharmaceuticals, cosmetics, agricultural products and food industries. For instance, the 
synthesis of the artificial sweetener L-aspartyl L-phenylalanyl methyl ester (Aspartame) 7 starts 
from L-aspartic acid 6. L-aspartic acid is synthesised from fumaric acid 5 by aspartase-catalysed 
addition of ammonia. When using immobilised aspartate β-decarboxylase with L-aspartic acid 
6, the amino acid L-alanine 8 can be formed (Scheme 4).9 
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However, despite the advantages of using biocatalysis, biocatalysts have limitations, for 
example, stability issues at high or low temperature and pH. In addition, they can only be used 
in a limited number of transformations, moreover, biocatalysts can be very sensitive, 
precluding the use of many solvents. 
 
1.1.3 Organocatalysis 
Organocatalysts are small chiral organic molecules mainly containing C, H, O, N, S and P 
atoms. Over the last 20 years, organocatalyses have had large successes and improved rapidly, 
due to their easy syntheses, low cost, low toxicity and their potential in several reactions. 
Moreover, another advantage is to reduce the high cost of drug production by synthesising 
different types of compounds and functional groups. 
Cinchona alkaloids are a type of natural product that were used in the first asymmetric 
organocatalytic reaction reported. The quinuclidine ring can act as a Lewis base,10 a 
nucleophilic catalyst,11 and it can act as phase transfer catalyst after it has been alkylated.12 In 
addition, these alkaloids have a hydroxyl group that can act as hydrogen bond donor or acid, 
or it can be converted to an amine group that can also act as hydrogen bond donor or as an 
aminocatalyst (Figure 1).13 
 
5 
 
 
In 1912, Bredig and Friske used quinine and quinidine as chiral catalysts in the first asymmetric 
organocatalysed reaction,13 used to synthesise mandelonitrile, by addition of HCN to 
benzaldehyde. The enantiomeric excess of the reaction was about 8%.14 Quinine was used 
again as a catalyst in 1960 by Pracejus, who used O-acetyl-quinine 11 with methanol and 
phenylmethylketene 12, to give product 13 in a quite remarkable 74% ee (Scheme 5).15,16 
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1.2 Types of organocatalysts 
 
Due to the larg number of organocatalysts that have different functional groups and are used in 
various synthetic transformations, their classification is difficult. However, organocatalysts can 
be classified depending on their mode of activation of the substrate, and that could be further 
divided into two parts, covalent and non-covalent. 
 
1.2.1 Examples of non-covalent organocatalysts 
A non-covalent catalyst does not involve sharing of electrons and instead involves electrostatic, 
hydrophobic and Van der Waals interactions. An example of non-covalent catalysts are phase 
transfer catalysts: the asymmetric induction occurs due to the chiral environment provided by 
the chiral ion and the ion also allows a reactant to migrate between the organic and aqueous 
phases. That can be done, for example, by generating an onium-carbanion species: in 1997, 
Corey used chiral ammonium salt 15 as catalyst to alkylate glycine-benzophenone Schiff base 
14, giving a yield of 71% and very huge ee of 97% (Scheme 6).  
 
 
In the example shown in scheme 6, at the interface, glycine Schiff base 14 reacts with 
CsOH.H2O, an inorganic base, to give the corresponding metal enolate. The metal exchanges 
with the ammonium cation catalyst creating a chiral environment, and finally alkylation gives 
the product and regenerates the catalyst. 17 
 
In 2000, Jacobsen used thiourea-based organocatalysts in the Strecker reaction through 
hydrogen bonding to activate HCN to add to the N-benzyl imine. The catalyst 16 provides 
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hydrogen bonding from the urea moiety, and the asymmetric induction is directed by the α-
amino acid and trans-1,2-diamino cyclohexane moieties (Scheme 7).18 
 
 
 
 
1.2.2 Examples of covalent organocatalysts 
Electron-sharing between catalysts and reactants during the reaction is called covalent bonding 
and is used, for example, during atom transfer in epoxidation and aziridination reactions, Lewis 
base catalysis and aminocatalysis. 
In 2002, the Fu group synthesised planar chiral DMAP derivatives which act as Lewis base 
organocatalysts due to the presence of a pyridine moiety.  
The C-acylation reaction of silyl ketene acetals 18 using acetic anhydride catalysed by DMAP 
derivative 17 occurs following these mechanistic steps: the acylpyridinium ion is generated by 
reaction between the DMAP catalyst and acetic anhydride, the resulting acetate ion affords a 
reactive enolate when reacting with the silyl ketene acetal substrate, and finally, a coupling 
step between the enolate and the acypyridinium gives 19 in high ee and reasonable yield 
(Scheme 8).19  
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In the field of aziridination and epoxidation reactions, the Page group has obtained impressive 
results.20,21,22 Moreover, Page reported reasonable to excellent enantioselectivities for the 
oxidation of dialkyl sulfides using hydrogen peroxide in the presence of 
oxocamphorsulfonylimine catalyst 20.23,24 The reaction between imine catalyst 20 and 
hydrogen peroxide gives a very reactive oxidative intermediate which can transfer the oxygen 
atom to the sulfide enantioselectively (Scheme 9).25  
 
Denmark applied chiral phosphoramide catalyst 22 to an asymmetric intermolecular aldol 
reaction for the first time in 1999. Denmark achieved excellent results in terms of yield and ee: 
at low temperatures, several α-β unsaturated, branched aliphatic and aromatic aldehydes were 
used as substrates with a reactive silyl enol ether as nucleophile (Scheme 10).26  
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One year later, Denmark proposed a mechanism for the reaction and its transition state. The 
trichlorosilyl enolether would undergo ionisation in the presence of the phosphoramide catalyst 
allowing the formation of a hexa-coordinated silicon centre from the cationic dichlorosilyl 
enolether, the aldehyde and the catalyst giving the anti-product.27 
 
In 2002, the MacMillan group reported Friedel-Crafts type alkylations of pyrroles and indoles 
with enals using secondary amine 23 as the catalyst. Co-catalysts, such as trifluoroacetic acid, 
improved the reaction rate and allowed the reaction to take place at low temperatures giving 
high selectivity.28 (Scheme 11). This type of catalysis, which can be classified as activation of 
carbonyls, is called aminocatalysis. 
 
 
 
 
 
 
10 
 
2.0 Mechanisms of aminocatalysis 
 
Iminium species 25, can be formed by condensation of a primary or secondary amine 24 with 
an aldehyde or ketone, and the resulting iminium can equilibrate into its enamine 26 tautomer. 
Both these intermediates are very reactive and can easily combine with reaction partners 
(Scheme 12).  
 
 
 
The iminium or enamine moiety is hydrolysed to free the amine catalyst after completion of 
the catalytic cycle.  
 
2.1 Iminium activation 
An iminium species is considered as an electrophile. Indeed, polarisation of π- electrons toward 
the positively charged nitrogen centre lowers the energy of the lowest unoccupied molecular 
orbital (LUMO) which increases the potential for combination with the highest occupied 
molecular orbital (HOMO) of the nucleophile. 
 
2.2 Enamine activation 
In contrast, enamine moieties are considered as nucleophiles, and their activity results from a 
higher energy of their highest occupied molecular orbital (HOMO), when compared with the 
parent carbonyl (Scheme 13). 
11 
 
 
Keto-enol tautomerisation is similar to the conversion of an iminium to the corresponding 
enamine species. Nevertheless, in the case of keto-enol tautomerism, the ketone is favoured, in 
contrast, in the iminium-enamine system, the enamine is favoured.29 
 
2.3 Non-selective aminocatalysis 
In 1896, Knoevenagel reported the first non-selective aminocatalysis using primary and 
secondary amines and their salts, applying them to the aldol condensation of β-keto esters and 
malonates with aldehydes and ketones (Scheme 14).30  
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C-C bond-forming is highly important in organic synthesis, in particular for industry; as a 
result, the development and study of aminocatalysts was targeted. For example, in the case of 
the Knoevenagel condensation, the primary amino acids catalysts used, and the secondary 
amines used to catalyse self- and cross-aldol condensations of aldehydes, were extensively 
studied.31,32  
 
2.4 First asymmetric organocatalytic reactions 
L-Proline 27 was used in an intramolecular aldol reaction with triketone 28 by Hajos and 
Parrish in 1971, 33 and that reaction was named the Hajos–Parrish–Eder–Sauer–Wiechert 
reaction.34 In 1950, Miescher and Wieland synthesised and used achiral piperidinium and 
pyrrolidinium salts to give the racemic dione 29,35 15 years later, the formation of enamine and 
iminium ion intermediates was suggested by Spencer et al. as the reason for the accelerating 
reaction rates.36 In 1984, Agami et al. shared the same idea, and they discovered that the attack 
of the nucleophilic carbon atom, in the case of a chiral enamine, differentiates between the two 
enantiotopic carbonyl groups (Scheme 15).37 
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According to Hajos and Parrish, the role of L-proline was similar to that of an enzyme, and 
could be considered a simplified model of a biological system. They suggested an intermediate 
with amino and carbinol groups (Figure 3).  
 
 
However, after further studies and investigation were carried out, Rutter proposed an aldolase 
class 1 mechanism, where the formation of enamine and how it reacts in the aldol reaction with 
the carbonyl group is described.38,39 In addition, in 1974, the amino acid sequence of the rabbit 
muscle aldolase was reported by Chang et al. Moreover, they mechanistically showed the 
lysine active site position prefers enamine and iminium ion catalysis.40 
 
Barbas and Lerner et al. worked on aldol reactions using antibodies, and they suggested that 
the antibody mechanism cycle is the same as the natural class 1 aldolase enzymes.41 Using the 
38C2 antibody, the Hajos–Wiechert Robinson annelation produced, amongst several other 
examples, the Wieland-Miescher ketone 30 in 94% yield and 96% ee. In contrast, when (S)-
proline was used, the product was obtained in 83% yield and 71% ee (Scheme 16).  
 
 
In addition, the mechanism of the Hajos– Parrish–Eder–Sauer–Wiechert reaction was proved 
using 18O-enriched water, following the reaction by GC-MS.42  
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Under completely air- and moisture-free conditions, during the running of the reaction, the 
product mixture was analysed and shown to contain aldol addition product 31, aldol 
condensation product 32 and dienamine 33. There was a single 18O atom incorporated in 31 
and 32 as their molecular ions were two mass units higher than the corresponding 16O products; 
furthermore, the dienamine did not incorporate 18O, showing that the carbonyl group is where 
the addition occurs, as is proposed in the enamine mechanism, and after hydrolysis of the 
iminium ion using 18OH2, the carbonyl group is regenerated (Scheme 17). 
 
 
 
In 2001, to explain the selectivity when proline is used, Houk used density functional theory 
(DFT) mechanistic studies (using B3LYP and 6-31G basis set in Gaussian 98). Houk studied 
the intramolecular aldol reaction of 4-methyl-heptane-2,6-dione 34.43 He suggested that four 
diastereoisomeric aldol products can be formed, and the favoured product was the (R,R)-
cyclization product 38, which was synthesised by hydrolysis of (R,S)-iminium species 37. In 
addition, he proposed that the rate-determining step of the reaction is the enamine attack on the 
ketone (Scheme 18). 
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The formation of the (R,R)-diastereoisomer is due to favourable electrostatic interactions 
between the positively charged proline iminium moiety and the alkoxide ion in the (R,S)-
transition  state 37. The electrostatic interactions were calculated for the (R,S)-transition state 
and the δ+NCH--Oδ- distance is 2.5 Å. In contrast, the (S,R) transition state 41 has a calculated 
δ+NCH--Oδ- distance of 3.2 Å: the 1 kcal/mol difference in energy would afford a 42% ee. The 
energy of transition state (R,S) 37 is lower due to hydrogen bonding, which allows the iminium 
bond to be mostly planar. Indeed, the formation of the hydrogen bond is important in the 
reaction as it affords enhanced charge stability for the alkoxide ion, resulting in the 
enantioselectivity observed (Figure 4).44  
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Wieland-Miescher ketone analogues, such as octahydronaphthalene dione 43, are very valuable 
intermediates in organic synthesis and have been used in the total synthesis of steroids 
cortisone, norethindrone and progesterone 44 (Scheme 19).45,46,47 
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3.0 Examples of asymmetric aminocatalysis 
 
List, Lerner and Barbas in 2000 reported using L-proline in direct asymmetric aldol reactions, 
drawing attention to asymmetric aminocatalysed reactions, and suggestion that the 
enantioselectivities would enormously increase in the further considering the chiral pool 
available for these aminocatalysts. 
 
3.1 Asymmetric aminocatalytic aldol reaction 
 
The aldol reaction is a very important reaction due to its ability to form a new carbon-carbon 
bond. Furthermore, the possibility of selectively forming one or two new stereogenic centres 
in the resulting β-hydroxy carbonyl compound is extremely attractive. 
 
 
 
L-Proline 27 was used in asymmetric aminocatalytic intermolecular aldol reactions by List et 
al. for the first time in 2000 (Scheme 20 and 21).49 Proline, as a chiral pool catalyst, exhibited 
similar features to aldolase antibody 38C2, an efficient catalyst for many reactions, such as the 
Wieland-Miescher ketone synthesis. Indeed, proline reacts via an enamine intermediate.50  
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High yields and enantioselectivities were obtained and a large number of aldehydes were tested 
using acetone as the only nucleophile (Table 1). 
 
 
 
After a comprehensive solvent screening, they found that the best solvent, considering reaction 
times and enantioselectivity, was anhydrous DMSO at room temperature. The highest ee was 
obtained when isobutyraldehyde 45 was used as the substrate, although a longer reaction time 
was required when compared with other aldehyde examples (48h vs 2-8h). In addition, the 
selectivities observed were much lower when aromatic aldehydes were used (Entries 2 and 3). 
However, unbranched aldehydes such as pentanal did not give the aldol product. To avoid the 
formation of self-aldolisation products azomethine-ylide 47, oxazole 48 or oxazolidinones 49-
50, acetone were used in high concentration.  
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In 2010, Gschwind et al. reported the proline-catalysed self-aldolisation of propionaldehyde as 
a model, trying to isolate the ‘elusive’ enamine intermediate and the by-product from the 
reaction.51 As a result, the enamine intermediate and two diastereoisomeric oxazolidinones 49 
and 50 were identified (Scheme 22). 
 
 
 
In more detail, the formation of an oxazolidinone comes from the condensation of proline with 
a ketone or aldehyde substrate followed by a ring-closing step, and that step is called ‘a parasitic 
equilibrium’.54 The iminium intermediate 46 is key to the interconversions between aldehydes, 
oxazolidinones and enamine formations.52 Moreover, the E-enamine intermediate was not 
obtained directly from the iminium intermediate, but was formed via oxazolidinones 50 
through an E2 mechanism as observed using NOESY NMR exchange spectroscopy.51,53 
Furthermore, the studies tested the effect of water presence on the reaction, and a reduction of 
the quantity of oxazolidinone was observed as the iminium ion 46 was hydrolysed to proline.  
 
 
20 
 
List et al. attempted a similar study using 1,3-dicarbonyl compounds as substrates. In this case, 
thermodynamic effects disfavour the formation of the corresponding oxazolidinones. Indeed, 
the extended conjugation favours enaminone isomer 51 (Scheme 23).  
 
 
 
In more detail, the enaminone 51 intermediate has the same electronic properties as an enamine 
when reacting with an electrophile. The electron density of both is removed away from the 
electron rich enamine-π-system. A study of crystal structures showed that the conformation for 
the enamine double bond is always (E) and relatively the position of the carboxylate is anti or 
syn to the enamine double bond.54  
Proline also gives very interesting results in many reactions, such as, carbon-carbon bond 
forming reactions (Michael reaction,55 aldol-modified dihydroxylation,56 cross aldolisation of 
non-equivalent aldehydes57) and heteroatom introduction reactions (α-oxygenation of 
aldehydes with nitrosobenzene,58 and α-amination of aldehydes with diazodicarboxylates59,60). 
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3.2 Asymmetric aminocatalytic Mannich reaction 
 
The Mannich reaction is another example of a carbon-carbon bond-forming reaction, giving β-
amino-carbonyl compounds, which are very useful intermediate in natural product syntheses, 
such as alkaloids. The imine (or iminium) derived from a primary (or secondary) amine and an 
aldehyde (usually) acts as an acceptor, while the enolate issued from a carbonyl-containing 
compound acts as the donor.  
 
After the huge success of L-proline in the asymmetric aldol reaction, List decided to apply L-
proline to a direct catalytic asymmetric three-component Mannich reaction based on a report 
by Kobayashi (Table 2).61,62 
 
 
 
List examined reactions of several aldehydes with p-anisidine and acetone; the highest ee 
(94%) was observed when 2-naphthaldehyde 52 was used but the yield was a modest 35%. In 
addition, when a β-substituted aldehyde was used, such as isovaleraldehyde 53, high ee and 
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yield (93% and 90%, respectively) were obtained. The mechanism of the asymmetric Mannich 
reaction starts with the proline reacting with the ketone to give the corresponding enamine 
species, while anisidine reacts with the aldehyde to form the corresponding imine intermediate. 
Condensation of the two species followed by hydrolysis gives the Mannich product (Scheme 
24). 
 
 
In 2001, List proposed a transition state corresponding to the C-C bond formation step of the 
Mannich reaction. They assumed that the proline-derived enamine and the anisidine-imine 
have the (E)-configuration and due to steric repulsion of the PMP group and the pyrrolidine 
moiety of the enamine, the enamine selectively attacks the si-face of the imine (Figure 5). 63  
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4.0 Proline-derived catalysts 
Proline proved to be a very versatile catalyst as well as a very successful one in terms of both 
enantio- and diastereoselectivity; in addition, proline can be cheaply bought in both 
enantiomeric forms. Nevertheless, there are some limitations using proline, such as solubility 
issues with all solvents except very polar solvent (methanol, dimethyl sulfoxide and water), 
which minimise its applications. Moreover, a high loading of proline is needed to achieve 
reaction completion in reasonable time.  
List screened some examples of commercially available amino acid derivatives in the aldol 
reaction of acetone with 4-nitrobenzaldehyde 54 with the purpose of understanding the 
structure-activity of the secondary amine catalysts (Table 3). 
  
 
 
As a result, the pyrrolidine ring, acting as a Lewis base, was found to be essential for selectivity 
and activity. In addition, in order to provide the asymmetric induction, the carboxylic acid 
24 
 
group was also found to be essential. The carboxylic acid group acts as a Brønsted acid co-
catalyst, promoting the formation of the iminium ion, and improves selectivity through the 
hydrogen bonding between the enamine and imine species enabling enantiofacial 
discrimination. Proline has bifunctional properties, allowing both Brønsted acid and 
nucleophilic Lewis base catalysis via enamines and iminium ions.49 
 
In 2004, and due to proline solubility issues in classic solvents, Ley synthesised tetrazole 58 
and acyl sulfonamide 60 in an attempt to keep a similar pKa to that of proline (Scheme 25).64,65 
In more detail, beginning with N-benzyloxycarbonyl-L-proline, a coupling reaction using 
ammonia, EDAC and HOBt provided amide 55 in quantitative yield, followed by a dehydration 
step in the presence of p-TsCl to give the nitrile compound 56.66 Addition of sodium azide 
afforded the tetrazole product 57 and deprotection of Cbz group gave the catalyst 58 in 89% 
yield. 
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The acyl sulfonamide catalyst 60 was prepared from the same starting material, which reacted 
with EDAC and methanesulfonamide in the presence of  DMAP, followed by a protecting 
group removal to give the catalyst. Both catalysts were applied to the Mannich reaction 
between cyclohexanone and imine 61 (Table 4). 
 
 
 
When catalyst 58 is compared with proline, the reaction is significantly faster as well as more 
selective (when the loading is 5 mol% for both) (entry 2). A longer reaction time is required 
(16 h) if the catalyst loading is lowered to 1 mol% and the same ee is obtained. However, in 
the case of catalyst 60, after a 25h reaction time a 1% and 5% catalyst loading afforded the 
product in 53% yield and 40% ee, and, 65% yield and, 83% ee, respectively. The 
diastereoselectivity in both cases is similar. Ley also confirmed Houk’s suggestion that the 
hydrogen bonding is providing a rigid chiral environment; in addition, the imine protecting 
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group p-methoxyphenyl is axial to avoid any gauche interaction with the tetrazole ring, giving 
syn-product 62 (Scheme 26). 
 
 
 
Ley also applied the tetrazole catalyst 58 in nitro-Michael, aldol and N-nitroso aldol 
reactions.67,68  
 
In 2004, Jørgensen reported the first direct organocatalyzed enantioselective sulfenylation of 
aldehydes. Isovaleraldehyde was used as the model. He started his examination with L-proline, 
which gave a racemic mixture and low yield (16%). He then synthesised several proline 
derivatives, such as 63. The results suggested that the presence of different groups such as aryl 
and silyl would provide high selectivity (Table 5). 
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Diarylmethylpyrrolidine 66 afforded the desired product in 56% yield and 25% ee (Entry 2). 
However, diarylprolinol 67 did not provide the desired product (Entry 3), and Jørgensen 
realised that the catalyst was fully converted into oxazolidine 69 (Scheme 27). To improve the 
results, catalysts with increasingly bulky groups, such as catalyst 63 and 68 were synthesised. 
69  
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After the successes observed using Jørgensen catalyst 63, it has been used in many reactions: 
benzylation of α,β-unsaturated aldehydes,70 cycloaddition reactions,71,72 aziridinations of 2,4-
dienals,73 epoxidations of α-β unsaturated aldehydes,74 α-aminations of aldehydes75 and α-
fluorinations of aldehydes.76  
 
As aminocatalysts have two modes of action, in 2006, Enders reported the use of diarylprolinol 
catalyst 68 in Michael/Michael/aldol condensation cascades in order to produce tetra-
substituted cyclohexene carbaldehydes with multiple stereogenic centres (Scheme 28).77 
 
 
 
In more detail, enamine formation occurs by condensation of aliphatic aldehyde 70 and catalyst 
68, a chemoselective step, followed by a Michael-type addition reaction with β-nitrostyrene 
71, a Michael acceptor more reactive than cinnamaldehyde, the other acceptor present. 
Hydrolysis of the product affords γ-nitroaldehyde product 73 and liberates the catalyst 68, 
which condenses with cinnamaldehyde to form the corresponding iminium ion. The newly 
formed iminium species reacts with γ-nitroaldehyde 73 to form enamine 74. Finally, an 
intramolecular aldol condensation step affords polyfunctional cyclohexene derivative 75, 
which is too sterically hindered to undergo further transformations, stopping the catalytic cycle. 
During this reaction cascade, four stereogenic centres are generated, therefore, up to 16 
different stereoisomers could possibly be obtained. However, only two easily separated 
diastereoisomers are formed.78 The high stereoselectivity in the Michael addition leads to 
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increased selectivity during the second step through sterically favourable interactions between 
the iminium ion and γ-nitroaldehyde 73 (Scheme 29). 
 
 
 
5.0 Axial chirality 
Chirality in a compound can also form from planes, helices or axes, bringing the possibility of 
a new design for asymmetric catalysis.  Axial chirality is encountered in compounds such as 
allenes, 2,2-disubstituted binaphthyls and tetra-ortho-substituted biphenyl compounds (where 
the rotation is prevented due to the steric effect of the substituent groups). 
 
In the biaryl system, stereoisomers resulting from the hindered rotation are called 
atropoisomers; indeed, the steric strain barrier to rotation is very high, allowing the isolation 
of conformers,79,80 which can be specifically targeted and used in asymmetric catalysis.81 In 
addition, the stability of configuration and the stereochemical environment made these type of 
catalysts popular worldwide, including for mechanistic studies.82 Atropoisomerism can also be 
found in several drugs, natural products, chiral auxiliaries, and lately organocatalysts.  
 
30 
 
One of the most famous axial chiral compounds is probably BINAP 76, due to its huge success 
as a selective ligand resulting from its high stability towards axis rotation and the potential for 
coordination with a variety of metals.83 A good example of an axially chiral natural product is 
(–)-steganone 77, an anticancer agent (Figure 6). 84  
 
 
 
5.1 Axially chiral aminocatalysts 
 
Due to the success of L-proline and its derivatives, it has been studied extensively. However, 
proline has a major drawback as it can decompose through decarboxylation.85 Therefore, 
modifications of the proline structure were targeted, particularly introducing more functional 
groups, and led to increased solubility and reactivity. 
 
Shi’s prolinamide catalysts (S)-78 and Maruoka’s amino acid catalyst 79 were excellent 
examples of axially chiral amino acid catalysts for the aldol reaction.86, 87 Prolinamide (S)-78 
was applied for acetone addition to aryl aldehydes. For a 10 mol% catalyst loading and after 
optimisation, the best results were obtained using 10 mol% of acetic acid as an additive in 
toluene at −40 °C giving up to 98% ee, high dr (>98:2) and up to 90% yield. Comparing 
catalysts 78 and 80 (synthesised by Tang and his group88), the selectivity obtained using 78 
was higher, but a longer reaction time was needed. The higher selectivity can be explained by 
the presence of an extra aminocatalytic centre and the binaphthyl backbone, which increased 
the steric bulk and the chiral influence (Table 6). 
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In addition, Maruoka compared his catalyst to L-proline in DMSO, with acetone and 4-
nitrobenzaldehyde as the substrates using a 5mol% catalyst loading. The kinetic study showed 
that although the initial rate of the reaction is high in the beginning when using proline, 
formation of oxazolidine (48%) caused a consumption of proline leading to a poor 18% yield. 
In the case of catalyst 79, no by-product is obtained, and the aldol product is obtained in higher 
yield (Table 7). 
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The use of amide-based solvents such as 1-methyl-2-pyrrolidone and N,N-dimethylformamide 
helped to improve the yield to 78% and 82%, respectively. Moreover, most aldehyde substrates 
gave ee above 90%. However, aromatic aldehydes gave low yields, whereas heteroaromatic, 
electron-deficient aromatic and olefinic aldehydes gave acceptable to very good yields. 
 
Maruoka used catalyst 79 (10 mol %) with cyclohexanone and a range of aldehydes in dimethyl 
sulfoxide to obtain most of the aldol products in excellent enantioselectivities, 
diastereoselectivities and yields. In contrast, benzaldehyde and β-naphthylaldehyde gave low 
yields. The anti-aldol 81 was the major product, determined by chiral HPLC to be the (2S,1R)-
diastereoisomer, which could be explained by a transition state in which the re face of the anti-
enamine approaches the re face of aldehyde (Table 8), (Figure 6) .89 
 
33 
 
 
 
 
 
 
 
 
34 
 
5.2 Maruoka’s organocatalysts 
 
A number of successful axial chiral organocatalysts were synthesised by Maruoka and they can 
be classified according to their mode of action as enamine (82, 84, 85),90 iminium (83),91 or 
phase transfer (86)92 catalysts (Figure 7). 
 
 
Maruoka relied on biaryl chiral backbones, based on their high chemical stability as well as 
allowing easy derivatisation.95 Furthermore, the design of the catalyst includes different aryl 
pendant functionalities, which provide different electronic properties tailored for different 
reaction types and conditions.  
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5.2.1 Aldol reaction  
Maruoka realised that catalyst 79 could be improved as the low nucleophilicity of the benzylic 
amine moiety slowed down the reaction rate, requiring a 10 mol% catalyst loading to achieve 
high yields. As a result, he synthesised catalyst 82, introducing electron-donating methoxy 
groups to increase the nucleophilicity of the amine moiety (Scheme 30). 
 
 
The synthesis start with a reduction of the dicarboxylic acid compound 87 by borane-dimethyl 
sulfide (BMS) to make the corresponding diol product, followed by a bromination step using 
bromine and pyridine at −20 °C to give the product 88 in 95% yield over 2 steps. The diol 
product 88 was converted to the dibromide 89 in 75% yield using phosphorus tribromide at 
room temperature. A double nucleophilic substitution with allylamine to introduce the amine 
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moiety afforded the product 90 in 99% yield. The ethyl ester moiety was introduced using n-
BuLi and ethyl carbonate to give product 91 in a moderate 48% yield. Deprotection of the allyl 
group using palladium followed by hydrolysis of the ethyl ester gave catalyst 82 in high yield 
(Scheme 30). 
 
Maruoka suggested that having the methoxy groups in the biphenyl backbone catalyst 82 
should increase the nucleophilicity of the catalyst, making it more reactive. A loading study 
confirmed the hypothesis: using catalyst loadings as low as 0.1 mol%, ee and yields remained 
excellent at the expense of a longer reaction time (Table 9). 93 
 
 
 
5.2.2 Diels-Alder reaction 
Using diamine catalyst 83 in an exo-selective Diels-Alder reaction gave a high selectivity with 
co-catalysts such as p-toluenesufonic acid. The Diels-Alder reaction, between α,β-unsaturated 
aldehydes and cyclopentadiene, gave high diastereo- (up to 20:1) and enantioselectivities (up 
to 95% ee). However, when other dienes, such as 1,3-cyclohexadiene and 1,3-pentadiene, were 
used, only trace amounts of the Diels-Alder adduct were observed (Table 10).94 
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Different electron-donating and –withdrawing groups were introduced and tested, and catalyst 
83 allowed a fast iminium salt formation and hydrolysis. Diphenyl groups were introduced at 
positions 3- and 3’, which increased the exo selectivity and enantioselectivity. Introduction of 
tert-butyl groups at the same positions led to further increase of the exo selectivity and 
enantioselectivity as well as shorter reaction times. The presence of a larger group blocks one 
face of the iminium species allowing the other face to be easily approached by cyclopentadiene. 
Furthermore, the presence of two methylamino groups in the catalyst accelerated the reaction 
rate according to NMR studies.95 
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5.2.3 Mannich reaction 
An anti-Mannich reaction between activated ketamine 92 and several aldehydes substrates 
using amino sulphonamide catalyst 84 was reported to give excellent results (Scheme 31).96 
 
 
Because the anti-Mannich product was the only product obtained, Maruoka proposed a 
different transition state model whereby only the s-cis enamine is reacting, probably due to the 
longer distance between the amine species and the carboxylic acid than in the case of L-proline. 
Indeed, the L-proline catalysed reaction, via a s-trans enamine transition state, predominantly 
gave the syn product (Figure 8). 97  
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5.2.4 Hydroxyamination of aldehydes 
Catalyst 85 based on Jørgensen’s catalyst 67 was synthesised and tested and led to the α-
aminoxylation reactions between aldehydes and nitrosobenzene in very high diastereo- and 
enantioselectivities (Figure 9).98 
 
The reaction between aldehydes and nitrosobenzene 94 can produce one of two products 
depending on the catalyst used. An O-nitroso aldol product 95 can be formed using tetrazole 
58, proline and glycolic acid.99, 100, 101 The presence of the acid enables hydrogen bonding and 
causes the nitrosobenzene 94 to act as an oxy-electrophile resulting in the formation of α-
nitroso-aldehydes. The N-nitroso product or hydroxyamination product 96 can be formed using 
tertiary alcohols such as TADDOL, with a pre-formed enamine (Scheme 32). 
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Maruoka wanted to find a pathway to achieve hydroxyamination products: using propanal and 
nitrosobenzene. Amine 97 was tested first to provide a reference free of hydrogen-bond donor. 
The ratio between the hydroxyamination and O-nitroso aldol products was very high (>99/1), 
but, the yield and ee obtained were low (22% and 29% (S), respectively). Alcoholic solvents 
were also examined, such as methanol and tert-butanol, increasing the yield slightly. In an 
attempt to improve the catalyst by targeting in-situ enamine formation and hydrogen bonding, 
two hydroxymethyl groups were introduced to form amine 100, resulting in a large increase in 
the yield and the enantioselectivity. Finally, catalyst 85 was found to be the best catalyst using 
the same conditions, providing high yields and excellent regio- and enantioselectivity (Table 
11) . 
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5.3 Page’s axially chiral atom transfer catalysts 
The Page group has been involved in the synthesis of several electrophilic atom-transfer 
organocatalysts, beginning from dihydroisoquinoline-based (101 and 102) evolving to more 
complex chirally axial backbones for epoxidation (103) and aziridination (104 and 105) 
reactions (Figure 10). 
 
 
5.3.1 Epoxidation catalysts 
Using a dihydroisoquinoline backbone and several primary amines, Page synthesised a range 
of catalysts which had a chiral exocyclic groups on the iminium nitrogen.102 Page introduced 
the chiral element close to the reaction centre hoping to improve the enantioselectivity. 
The synthesis of dihydroisoquinoline catalyst 108 started with bromination of isochroman to 
give 1-bromo-isochroman 106, and in the presence of hydrobromic acid, compound 106 was 
converted to 2-(2-bromoethyl)benzaldehyde 107 in a good 65% yield. A condensation step 
with acetonamine 109 afforded the iminium species followed by anion exchange with sodium 
tetraphenylborate to form catalyst 108 (Scheme 33). 
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In the presence of an oxidising agent such as oxone or TPPP, the iminium catalyst is converted 
into the corresponding oxaziridinium ion, followed by the oxygen atom transfer to the alkene 
substrates. Page also synthesised catalysts that have acetonamine 109 based chiral features 
using axially chiral biphenyl and binaphthyl backbones.103,104,105 
Catalyst 101, derived from isopinocampheyl amine, gave good ee (73%) when tested with 
trans-stilbene. However, the most successful catalysts having an acetonamine moiety, such as 
102, 103, 108 and 110, showing increased enantioselectivity when compared with other chiral 
amines. Catalyst 102 afforded the highest enantioselectivities (up to 97%) when used in the 
oxidation of cyclic cis-alkenes in the presence of TPPP at low temperatures (Table 12).106 
 
 
43 
 
Page applied catalyst 102 to the synthesis of antihypertensive (−)-cromakalim 112 by forming 
epoxide product 111 followed by an epoxide ring-opening reaction using 2-pyrrolidinone to 
give the (−)-cromakalim (Scheme 34).107 
 
In the case of catalyst 108, epoxidation of triphenylethylene was achieved in moderate 
selectivity (59%). The selectivity could be due to the chair conformation of the dioxane 
substituent, as observed in the solid state by using single crystal X-ray crystallography, 
implying that the dihydroisoquinoline moiety is axial.108 
 
 
 
To avoid the 1,3-diaxial interaction present in conformer 108a, the thermodynamically 
favoured conformation becomes 108b, in addition, the oxygen atoms lone pairs could increase 
the stability of the iminium moiety further favouring 108b. The phenyl group probably shields 
one side of the iminium bond, therefore making attack on one face favoured (Scheme 35).  
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The catalytic cycle starts with the nucleophilic oxidant attacking the iminium species on its si 
or re face, potentially forming two diastereoisomers: 113a and 113b. As the phenyl group 
hinders the oxidant’s approach towards one face of the iminium species, the formation rate of 
the diastereoisomers will be different. Therefore, one of the ring closed oxaziridinium species 
114a or 114b will be formed preferentially. As a result, oxygen atom transfer to a prochiral 
alkene substrate will occur selectively (Scheme 36). 
 
Catalyst (S)-binaphthyl azepinium salt 103 gave phenyl-1,2-dihydronaphthalene oxide in high 
ee (95%) due to the axially chiral binaphthyl backbone. Furthermore, the Page group improved 
the biaryl iminium catalyst series by introducing a substituent at the α-position to the azepinium 
nitrogen atom thus increasing the steric constraint around the iminium species to improve the 
selectivity. In the case of biphenyl catalyst 110, where there is no barrier to interconversion 
between atropoisomers at room temperature, addition of the substituent locks the conformation, 
preventing the interconversion, and the formation of two separable atropoisomers is observed. 
 
 
In more detail, low-temperature 1H NMR experiments were carried out on catalyst 110 to 
observe the preferred lowest energy conformation. The rotation around the biphenyl C-C and 
N-C bonds allowed the detection of four conformers which were identified. The Rax 
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conformation (89:11) was favoured for the biphenyl species due to reduction of the interaction 
with the nitrogen substituent. Mixtures of two diastereoisomers were formed when Grignard 
reagents (methyl, isopropyl, phenyl, and benzyl) were added to iminium species 110 at −78 °C. 
For example, when methylmagnesium bromide was used, the major diastereoisomer was 
(Rax,R,S,S)-115 and was isolated alongside the minor diastereoisomer (Sax,S,S,S)-116 (Scheme 
37). 
 
 
 
As the rotation around the biaryl axis was prevented, the substituent adopted a pseudo-axial 
orientation to minimise its steric interaction with the acetonamine moiety. Using 1H NMR 
spectroscopic analysis, the chemical shift for 115 at δMe 0.68 ppm and 116 at δMe 0.41 ppm 
allowed the group to identify the configuration of the two atropoisomers; the chemical shift for 
the protons on the pseudo-axial methyl group is affected by the ring current effect causing 
deshielding. Single crystal X-ray crystallography confirmed the absolute configuration of 117 
to be (Rax,R,S,S). Through a double stereochemical relay, the two atropoisomers were produced 
selectively: the chiral group attached to the nitrogen favoured product 115 and in addition 
controlled the selectivity of the Grignard reagent addition.109 Such a stereochemical relay was 
observed by Wallace when conducting dynamic axial chirality studies. Azepine 118 has a (Sax) 
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biaryl backbone and the methyl group in position 5 is pseudo-equatorial. However, when 
azepine 118 is converted into N-Boc-azepine 119, the addition of a bulky N-Boc group forces 
a switch in the axial chirality of the backbone, and the α-substituent orientation switches to a 
pseudo-axial orientation (Scheme 38).110  
 
 
 
 
Steric interactions between the methyl group and the N-substituent force this switch: the methyl 
group adopts a pseudo-axial orientation to minimise the steric interaction with the Boc groups, 
which leads to a change of the biphenyl backbone chirality from (S) to (R).  
In the case of the binaphthyl compound 103, the Grignard reagents were introduced completely 
diastereoselectively (Scheme 39). 
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In order to prepare the catalysts, (Rax,R,S,S)-115 and (Rax,R,S,S)-120 were oxidised using NBS 
giving the corresponding iminium salts. The presence of the methyl group at the C5 position 
was shown to improve the selectivity of the epoxidation reaction of 1-phenyl-1-cyclohexene 
(Scheme 39), (Table 13). 
 
 
 
5.3.2 Aziridination catalysts  
In 2013, Page adapted the binaphthyl and biphenyl catalyst structures in order to probe their 
activity and selectivity in the aziridination reaction of chalcones. The modification introduced 
substituents at the 3- or 3,3’ positions as well as the introduction of different groups on the 
azepine nitrogen atom. 
 
Using O-(diphenylphosphinyl)-hydroxylamine (DppONH2) 122 as the nitrogen transferring 
reagent and NaOH as the base in dichloromethane was found to be the optimal conditions. 
Using 3,3’-disubstituted catalyst 104, a moderate 43% ee with a very low 10% conversion was 
observed, maybe due to steric hindrance. In addition, N-isopropyl azepine 105 gave higher 
conversion (70%) and a lower 35% ee (Table 14). 
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 Moreover, azepine 123 enabled the preparation and isolation of hydrazinium salt 124 in good 
yield (77%). Tetraphenylborate counter ion exchange gave product 125 in quantitative yield, 
which was found to be bench-stable for a long period of time (two years) (Scheme 40). 
 
 
 
Under the same condition, 124 and 125 were both used as aziridination reagents giving the 
same ee and yield as 123 which probably shows that hydrazinium salts are an intermediate in 
the catalytic cycle. 
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5.3.3 Page’s axially chiral aminocatalysts 
After the good results obtained using the axially chiral atom transfer organocatalysts, Page 
attempted to adapt the structures of his azepine compounds to be suitable as aminocatalysts. 
Starting with 97 and 126, binaphthyl aminocatalysts were prepared and compared with 
Maruoka’s successful amino-acid catalyst (S)-79 using the aldol reaction of 4-
nitrobenzaldehyde and acetone (Figure 11). 
 
 
 
Using Maruoka’s preferred solvents (dimethylsulfoxide or N,N-dimethylformamide), catalyst 
97 gave very poor conversions and racemic products. On the other hand, complete conversion 
to the aldol product in a low ee was observed when aprotic solvents, such as acetonitrile, 
acetone and tetrahydrofuran, were used. In addition, the major isolated enantiomer was the (S)-
enantiomer with all solvents apart from water, which gave the (R)-enantiomer in 16% ee. In 
the case of catalyst 126, generally, similar results in terms of ee and conversion were observed. 
Using acetonitrile at 0 oC, the (S)-enantiomer was obtained in 30% ee (Table 15).  
 
50 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
6.0 The project 
 
The aim of the project is to synthesise and design organocatalysts that share a similarity with 
catalysts reported before, such as proline 27, tetrazole 58,111 diarylprolinol silyl ether 68,112 and 
Maruoka’s amino acid 79. The novel targeted catalysts may have a stereogenic centre on the 
azepine ring and the structures will be axially chiral. Introducing different R substituents next 
to the nitrogen atom should lead to interaction with the in situ generated iminium or enamine 
species (depending on the reaction type) by hydrogen bonding, ionic or/and steric interactions 
to encourage increased enantiofacial selectivity, therefore, leading to highly enantioselective 
reactions (Figure 12). 
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Chapter two: Results and Discussion 
 
 
1.0 Project Aim 
 
The project aim is to synthesise novel axial chiral aminocatalysts, and test their efficiency on 
two asymmetric reactions, aldol and mannich reactions (Michael and Diels-Alder reactions 
have been evaluated previously in the Page group). Our design is similar to Maruoka’s aryl 
bifunctionalized organocatalyst 79, which showed excellent selectivity, but on the other hand, 
the addition of groups that are closer to the aminocatalytic centre has not been investigated on 
the BINAP system. Our catalyst would have conformational stability due to the fixed chiral 
backbone. In addition, as was proved successful with Page’s epoxidation catalysts, the 
stereogenic centre would be sited at an α-position with respect to the azepine nitrogen atom 
(Figure 13). 
 
 
 
The synthetic approaches until producing the binaphthyl azepines have been reported 
before.1, 2, 3 At the 2-position of the azepine ring, the Introduction of a substituent is rarely 
reported, except for a few reports of asymmetric additions of alkyl groups. However, there 
have been two successful approaches reported: The diastereoselective Grignard reagent 
addition on an iminium salt by Page, 4 and base-mediated alkylation method as used by 
Meyers, 5 Wallace6 and Superchi1. 
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Using the approach A is preferred when the protection group of the azepines is electron-
donating due to the stability of the iminium species. Where is approach B is preferred is 
when an electron-withdrawing group is protecting the azepines, as position α is been 
activated to be deprotonated (Scheme 41).  
 
2.0 Synthesis of the β-amino acid catalyst 
 Our first aim was to synthesise a catalyst analogous to proline. In addition, introduction of a 
carboxylic acid group was also considered. A number of β-amino acid proline analogues have 
been studied and their application tested in aldol reaction such as 1277 and Mannich reaction 
such as 1288 (Figure 14). 
 
 In more detail, comparing L-proline with these catalysts in the Mannich reaction between 3-
pentanone and α-imino amide 129 for example, resulted in a 73% yield when 130 used as 
catalyst after 3 days.9 In contrast, using L-proline gave <10% conversion after 3 days, proving 
that these catalysts have a higher reactivity than L-proline in this reaction. (Scheme 42)7.  
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In addition, the Hajos-Parrish-Eder-Sauer- Wiechert reaction of 131 catalysed by D-proline 
gave 72% ee while using 132 gave a higher selectivity of 86% ee (Scheme 43)8.  
 
Therefore, chiral β-amino acids seems very interesting as a catalytic design.  
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2.1 Initial retrosynthetic approaches to the β-amino acid catalyst  
Approach A was used in the synthesis of catalyst 133 starting from iminium salt as the Page 
group had developed this method. As the addition of Grignard reagents onto the azepinum 
species is totally diastereoselective, we aimed to introduced suitable nucleophilic reagents 
selectively following by conversion into the corresponding carboxylic acid 133 (Scheme 44).  
 
 
To allow iminium salt formation, a nitrogen protectiong group is essential, and in addition it 
is a fundamental synthetic step for the catalyst that can be removed easily. Furthermore, basic 
and nucleophilic conditions are important as is tolerance of oxidation. Previously in the group 
the p-methoxybenzyl group was introduced, which added more stability to the iminium 
moiety, but unfortunately decomposition accrued when its removal was attempted (Scheme 
45). As a result, the allyl amine group was targeted which was also applied in the Maruoka 
binaphthyl catalysts successfully.10  
 
 
 
61 
 
3.0 Azepine synthesis  
 We Started from enantipure (S)-BINOL to synthesise a range of binaphthyl catalysts.11 At 
low temperature a conversion of bis-alcohol to bis-triflate using triflic anhydride and 2,6-
lutidine gave 134 in quantitative yield. A methylation step by a Kumada cross-coupling 
reaction by using 1,2-bis-(diphenylphosphino)ethane dichloronickel(II) (Ni(dppe)2Cl2) with 
methyl magnesium bromide  gave 135. Formation of product 136 by a radical bromination 
reaction using N-bromosuccinimide and azobisisobutyronitrile as an initiator gave modest 
yields of 135 (between 47% to 77%) (Scheme 46).2  
 
 
The first three steps did not required using column chromatography as the products can be 
purified by recrystallization or precipitation, giving the products in high purity with complete 
retention of absolute configuration.  
Having a dibromo product will provide variety of tertiary azepines for future derivatization 
by a double nucleophilic substitution reaction which was a general reaction procedure as 
previously reported by Page to synthesise several highly substituted biphenyl azepines giving 
biphenyl products in moderate to high yield.12 The reaction could be carried out by treatment 
of the dibromo product 136 with small excess of a primary amine and heating under reflux in 
62 
 
the presence of anhydrous potassium carbonate in acetonitrile. By oxidation using NBS 
followed by anion exchange using sodium tetraphenylborate the corresponding iminium salt 
formed in a good yield of 81%. Our attention after having the iminium species, turned to the 
diastereoselective addition of nucleophiles (Scheme 47).  
 
 
4. Allyl protecting group  
Knowing the Page’s group previous difficulty in removing the PMB group, we focused on 
the allyl group, which is used widely to protect amine and alcohol moieties, and was also 
used by Maruoka.11 Tsuji’s original procedure used a palladium mediated allylation reaction 
by adding diethyl malonate to the ŋ3-diallyl dichlorodipalladium complex 139. This resulted 
in two products, mono- and bis-allyl.13 In addition, Trost’s is work in allyl protection resulted 
in short time reaction by addition of triphenylphosphine, and controlled use of the 
nucleophile in the addition to the ŋ3 complex by steric and electronic properties of the 
nucleophile. As an example reaction of methylsulfonyl acetate 140, the product 141 was the 
only one isolated.14 To remove the allyl protection group, N,N-Dimethylbarbituric acid 142 
was used as a nucleophilic allyl scavenger (Scheme 48).15 
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4.1 Oxidative cross coupling reactions  
Cross dehydrogenative coupling (CDC) reactions can take place by conversion of one 
reaction partner into an electrophile through in situ oxidization as an electron-rich coupling 
partner attacks. In this type of reaction, a high tolerance of function groups is involved. The 
reaction is capable of functionalizing sp3 C-H bonds with sp, sp2 and sp3 hybridized starting 
materials by using catalysts based on copper or iron salts (Scheme 49).16  
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There are many reports of  oxidations of C-H bonds close to nitrogen atoms in tertiary 
amines.17 A coupling reaction reported by Li et al. between tetrahydroisoquinoline 143 and 
dimethyl malonate (used as a solvent) in the presence of t-BuOOH (TBHP) and copper 
bromide catalyst (5 mol%), which was in mild conditions resulted in β-diester 
tetrahydroisoquinoline analogue 144 at room temperature in high yield of 90% (Entry 1).18 
In addition, Itoh reported the first use of iodine as a metal-free oxidative catalyst in CDC 
reactions of tertiary amines which was in the presence of hydrogen peroxide giving 144 in a 
good yield of 73% (Entry 2), (Table 16).19  
 
By applying the Li conditions to our protected allyl azepine 137, using the copper catalyst, 
nothing appeared except starting material in the reaction mixture after 24 h. It was assumed 
that this was due to the poor solubility of the azepine 137 in the solvent diethyl malonate. 
Furthermore, when dichloromethane was used as the solvent, unfortunately only starting 
material was observed. Use of Itoh conditions using the iodine with the oxidant hydrogen 
peroxide, afforded only of starting material, even when a higher temperature of 50 oC was 
applied (Table 17).  
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From a mechanistic view, generation of an electrophilic iminium ion is essential inder the Li 
and Itoh CDC reactions. Itoh suggested that by reaction between iodine and hydrogen 
peroxide, the hypoiodous acid (HOI) is formed, which is the active oxidant in the conversion 
of 143 into the iminium species. 
 Li proposed that copper can activate the dimethyl malonate and also coordinate to 143 to 
form an iminium intermediate by hydrogen abstraction at the α-position of 
tetrahydroisoquinoline. Excitingly, in a CDC reaction between tetrahydroisoquinoline 143 
and dimethyl malonate with DDQ as an oxidant by Todd, the reaction could not progress if 
the iminium ion 145 was not isolated and then added to the dimethyl malonate solution, 
resulting 144 after 30 min in 73% yield (Scheme 50).20  
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This could explain the failure of our CDC reactions with the azepine 137, so we decided to 
isolate the iminium salt first and then test the copper-catalysed coupling conditions.  
Azepine 137 was oxidized with NBS or DDQ followed by ion-exchange with sodium 
tetraphenylborate, resulting in the iminium salt 146 as an orange solid. Moreover, using NBS 
at room temperature gave a moderate yield of 51% (Entry 1), and, by lowering the 
temperature at 0 oC the yield increased to 79% (Entry 2). Using the DDQ at room 
temperature gave a lower yield of 43% (Entry 3), (Table 18).  
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After we had synthesised 146 in a good yield, the Li coupling conditions were examined, in 
the presence of additive TBHP and without (Table 19).      
 
After 16 h, only decomposition of the starting material, the iminium salt 146 was observed. 
No formation of the desired product was observed. 
Another method was tried for the CDC reaction by generating a reactive ethoxy intermediate 
148, which was prepared from isoquinolinium bromide 147 with sodium ethoxide. The 
ethoxide group was replaced by several ketones, use of acetone giving the highest yield 
(Scheme 51). 21   
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Unfortunately when tested on 146, no formation of the desired product was observed after 16 
h, both low and high temperature conditions giving only starting material (Table 20). 
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4.2 Reformatsky reaction        
The Reformatsky reaction uses organo-zinc reagents which can be formed from oxidative 
addition of zinc into carbon-halide bonds of α-halogen esters, 22 which when added to 
carbonyl containing compounds result in β-hydroxyester compounds (Scheme 52). 
 
 
The Reformatsky reactions has been used to introduce functionality onto several substrates, 
and has been most studied on aldehydes and ketones. However, addition to imine and 
iminium moieties has been only rarely reported.23 In addition, addition of α-haloesters to 
iminium salts were reported in alarge-scale in synthesis of an anti-arteriosclerotic 
intermediate (Scheme 53).24  
 
 
We decided to try the Reformatsky reaction with the iminium salt 146 as a Reformatsky 
reagent acceptor. As we predicted that the saponification step would involve mild conditions, 
t-butyl bromoacetate was used.  
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In more detail, a zinc suspension in tetrahydrofuran was heated under reflux in the presence 
of chlorotrimethylsilane and 1,2-dibromoethane for 1 h. Unfortunately, only trace amounts of 
the desired product 151 were obtained (Entry 1). By increasing the reagent amount, the 
desired product was isolated in 17% yield as a single diastereoisomer (Entry 2). In addition, 
leaving the reaction for a longer time of up to 48 h and increasing the Reformatsky reagent 
equivalents, a slight improvement in the yield was found at 24% (Entry 3). Trying to 
increase the yield the temperature was raised to 65 oC for 12 h, but unfortunately, due to 
instability of the Reformtsky reagent 150 or iminium salt 146 in higher temperatures, product 
151 was not obtained (Entry 4), (Table 21).  
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The iminium salt 146 was instable and therefore, a procedure using chiral N-sulfinyl imine 
153 which undergoes Reformatsky reactions at low temperature, was investigated. The 
corresponding ester 154 was formed in quantitative yield using a novel zinc activation 
method using DIBAL, which has also been reported for large scale synthesis (Scheme 54).25 
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At low temperature, the substrate 146 using DIBAL zinc activation gave ester 151 in 25% 
yield (Entry 1). We tried to improve the yield by activating the zinc with a stoichiometric 
amount of TMSCl, and adding the iminium salt 146 to the activated zinc slurry at 0 oC, which 
gave a higher yield of 43% (Entry 2). In addition, the iminium salt 146 was added to the 
activated zinc at -78 oC yielding the desired product 151 in 68% yield. A crystal structure of 
151 has been obtained in the Page group previously (Entry 3), (Table 22).   
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 The next step was removal of both the allyl and t-butyl protecting groups. Deallylation of 
151 led to the azepine product 155 in 82% yield, followed by removal of the t-butyl group 
using TFA to afford the β-amino acid catalyst 133 in a high yield of 91% (Scheme 55).  
 
 
 
Furthermore, we estimated that a more steric congested analogue of β-amino acid catalyst 
133 would gave more selectivity by increasing crowding near to the amine centre, and that 
led us to synthesise β-amino acid 156 (Figure 14). 
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The Reformatsky substrate was t-butyl bromoisobutyrate. A higher temperature was used, 
which gave a moderate yield of 47% (Entry 1). Moreover, decreasing the temperature to 0 
and -78 oC gave better yields of product 158, isolated in 52% and 74% respectively (Entry 2 
and 3), (Table 23). 
 
 
 
 
 
 
 
 
75 
 
After we had 158 in hand, deallylation under palladium-catalysed conditions gave product 
159 in 60% yield, and after the saponification step using TFA, product 156 was obtained in a 
moderate yield of 62% (Scheme 56). 
 
 
Further, we applied the same conditions to add methyl and ethyl esters, but we were only able 
to produce the β-methyl ester 160 (Entry 1), (Table 24).  
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To remove the allyl group, 160 was treated with palladium catalyst to give the β-methyl ester 
catalyst 161 in 63% yield (Scheme 57). 
 
5.0 Initial retrosynthetic approaches to the α-amino acid catalyst 
After we had successfully synthesised β-amino acids 133 and 156, and to evaluate the 
groups’ effect depending upon their distance from the catalytic centre. Therefore, the α-
amino acid 162 route was evaluated, 162 being which could synthesised through a lithiation 
and electrophilic trapping route (Scheme 58). 
 
 
The deprotonation step in approach B would require a metaleation of the binaphthyl azepine, 
which could be done using a metal hydride base or an organo-lithium. Use of electron-
withdrawing N-protecting groups was thought to be essential to deprotonate the proton at α-
position, because the protecting group would increase the acidity at α-position by 
stabilization of the anion intermediate.26 and that followed by addition of the electrophilic 
reagent which will quench the anion giving the α-functionalized catalyst.  
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5.1 Boc protecting group 
Starting from dibromo product 136 using tert-butyl carbamate in DMF with sodium hydride 
(2.1 equivalent) as base for 4 days, gave the Boc-protected product 163 in 54% yield (Entry 
1).27 Increasing the number of the equivalents of base to 3 and 4 showed improvement of 
65% and 87% yield respectively (Entry 2 and 3). Increasing the temperature to 50 oC and 
reducing the reaction time led to poor yield of 31% and inseparable side products (Entry 4), 
(Table 25). 
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Having the Boc-azepine 163 in hand, we investigated its deprotonation and alkylation with 
functional groups that could be converted into a carboxylic acid, for example by a 
saponification reaction. Therefore, deprotonation of Boc-azepine 163 at -78 oC with sec-BuLi 
followed by alkyl chloroformate addition which was carried out under Blakemore’s 
conditions gave good results.28 Addition of ethyl and methyl chloroformate gave good yields 
of 70% and 80% respectively (Entry 1 and 2). However, the addition of di-tert-butyl 
carbonate was unsuccessful (Entry 3), (Table 26).  
 
Only starting material was obtained upon trying to remove the Boc group using mild 
microwave heating in water.29 However, successful deprotection of the Boc group for both 
ethyl and methyl azepines using an excess of trifluoroacetic acid in dichloromethane gave 
166 and 167 in 85% and 81% yield respectively (Scheme 59).  
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Unfortunately, all saponification reactions that were examined for both the methyl and the 
ethyl esters failed. Further, basic and acidic conditions and higher temperatures were 
examined for both methyl and ethyl esters. However, only starting material was obtained. Use 
of TMSCl combined with NaI was tested, but surprisingly, instead of saponifying the methyl 
ester, the Boc group was removed (Entry 6).30 In addition, using hydrochloric acid under 
reflux also caused removal of the Boc group with the ethyl ester (Entry 4). Lastly, a complex 
mixture was found when hydrazine was used (Entry 9), (Table 27).31 
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Another approach was tested, by reduction of the ester group using lithium aluminium 
hydride. Unfortunately, only starting material was isolated when three equivalents of the 
reduction reagent was used with methyl ester 165 (Entry 2). Furthermore, we thought that 
the bulky tert-butyl group was the reason for the reduction not occuring. The free amine 167 
was therefore tested under the same conditions, but only starting material was obtained 
(Entry 1), (Table 28). 
 
After the failure of saponification of both esters 164 and 165, we found another approach to 
synthesise carboxylic acid 162 from a paper by Beak published in 1991.32 Beak attempted to 
introduce a carboxylic acid at the α-position of Boc-pyrrolidine 168 using sec-butyllithium 
with the chiral additive (-)-sparteine 167, which results in enantioselective deprotonation of 
the Boc-pyrrolidine 168, giving one enantiomer.To form product L-proline 170, carbon 
dioxide gas was bubbled into the reaction mixture of the deprotonated Boc-pyrrolidine 168, 
giving the desired compound 170 in 88% ee and modest yield of 55% (Scheme 60). 
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Following the same method and conditions, Boc-azepine 163 was dissolved in diethyl ether       
at -78 oC and sec-BuLi added to the solution for 1 h and CO2 gas was bubbled through the 
reaction mixture through CaCl3 drying tube. Two hours later, the reaction was quenched 
using saturated aqueous ammonium chloride. Both distereoisomeric acids 171 and 172 were 
obtained and isolated in 30% and 34% yield, respectively. In addition 12% yield of side 
product 173 was formed (Entry 1). There was little rise in the yield when the reaction was 
left longer. Increasing the number of equivalents of sec-BuLi and the reaction time resulted in 
a reduction in yield (Entry 3). Using the dry ice pellets as a source of the CO2 affected the 
yield for both distereoisomeric acids causing a minor decrease in yields (Entry 4 and 5) 
(Table 29). 
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Finally, deprotection of the Boc group using trifluoroacetic acid afforded the free amines 174 
and 175 in high yield (Entry 1 and 2), (Table 30).33 
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6 Catalyst testing 
6.1 Aldol reaction  
The aldol reaction between nitrobenzaldehyde 54 and acetone employing the catalysts was 
the first reaction used in our evaluation. With an aminocatalyst, the activation of the enamine 
from the ketone substrate can be achieved (Scheme 61). 
 
 
 
Our α 166, 167 ,174 , 175 and β 133, 156, 161 amino catalysts (Figure 15) share structural 
and function group similarities with Maruoka’s amino acid catalyst 79; his catalyst showed in 
the aldol reaction high e.e up to 99%  (Table 7 and 8); we hoped that our catalysts would 
provide similar results.34 
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Following the Maruoka and List conditions, using DMSO as a solvent with acetone and 4-
nitrobenzaldehyde 54, we first examined the α-carboxylic acids 174 and 175 as catalysts in 
DMSO and several solvents.  
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In the case of 174, unfortunately only starting material was obtained in all different solvents. 
On the other hand, catalyst 175 shows a poor conversion of 15% with 11% ee, and 17% 
conversion and a racemic mixture with solvents methanol and acetone, respectively (Entry 8 
and 6), However, an increase in conversion was observed when THF and ethyl acetate were 
used, although with poor ees of 9% and 8% respectively (Entry 4 and 5) (Table 31). 
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Due to the poor results we obtained from the α-carboxylic acid catalysts 174 and 175, we 
tested the α-ethyl and methyl ester catalysts 166 and 167 to check their efficiency in the same 
reaction screening with several solvents.   
In general the results were better compared with the carboxylic group. In the case of the ethyl 
ester catalyst 166, using DMSO gave 28% conversion with 17% ee (Entry 1). Whereas, 
using acetone gave an increase in the conversion of 44% but a lower ee was obtained of 4% 
(Entry 2). A racemic mixture with a slight decrease in conversion of 30% was observed 
when acetonitrile was used (Entry 3). Using methanol gave the highest result of 46% 
conversion and 17% ee (Entry 4). Starting material was obtained when ethanol was used 
(Entry 5). The methyl ester catalyst 167 gave a racemic mixture when DMSO and 
acetonitrile were used and gave 15% and 12% conversion respectively (Entry 1 and 3). A 
slightly improved conversion of 25% and 12% ee was seen when acetone was used (Entry 
2). A higher conversion was obtained using methanol of 51% but with low ee of 5% (Entry 
4). Lastly, only starting material was obtained when ethanol was used (Entry 5) (Table 32).  
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We also tested the β-amino catalysts starting with the carboxylic acids 133 and 156 screening 
with several solvents. Catalyst 133 gave 57% conversion and 19% e.e when the standard 
solvent DMSO was used (Entry 1). Acetone gave a higher conversion of 71% but with a 
lower ee of 10% (Entry 2), EtOAc gave the lowest conversion and e.e of 15% and 8% 
respectively (Entry 3), unfortunately no product obtained when acetonitrile and methanol 
were used (Entry 4 and 5). On the other hand, unfortunately, catalyst 156 did not give any 
product with any of the solvents, perhaps because of steric effects of both the methyl groups 
(Table 33). 
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In addition the β-amino methyl ester catalyst was screened with several solvents. Starting 
with DMSO giving a poor conversion of 5% with 11% e.e (Entry 1), an increase in 
conversion to 24% with a lower e.e of 8% was seen when acetone was used (Entry 2), and a 
slight increase of the conversion when ethyl acetate was used to 37% with 9% e.e (Entry 3). 
A racemic mixture was obtained with 50% conversion using acetonitrile (Entry 4), and no 
product was obtained when methanol was used (Entry 5) (Table 34). 
 
 
After we tested all the α-and β-amino catalysts, we chose the best conditions that we had 
found which were the α-ethyl ester 166 with methanol (Entry 4, Table 32) and the β-
carboxylic acid 133 with DMSO (Entry 1, Table 33), and tested them with several 
aldehydes. 
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Unfortunately, no aldol product was obtained for either catalyst 133 or 166 except that 
catalyst 133 gave a poor conversion of 27% and 21% e.e when 3-nitrobenzaldehyde was used 
(Entry 3) (Table 35).  
 
Unfortunately the results in the aldol reaction were not promising, and we therefore decided 
to test the ability of our catalysts in another reaction. 
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6.2 Mannich reaction  
After the failure of our catalysts in the aldol reaction, we considered the Mannich reaction to 
test our catalysts. Following List’s conditions using 4-nitrobenzaldehyde and p-anisidine we 
employed acetone/DMSO (1:4), and also tried several other solvents. 
 
We started with the α-amino carboxylic acids 174 and 175. Firstly, using catalyst 174, no 
product was observed using DMSO (Entry 2). Unfortunately the highest e.e we found was 
7% and the highest yield 32% using acetone as only solvent (Entry 3). Racemic product was 
observed with DCM, with a poor yield of 12% (Entry 4). Using ethyl acetate and chloroform 
gave poor results of 9 % yield, 5% e.e, and 16%  yield, 3% e.e respectively (Entry 5 and 6) 
(Table 36).   
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Secondly, we tested the ethyl and the methyl ester catalysts 166 and 167 using the same 
conditions and solvents. Beginning with ethyl ester 166, only starting material was obtained 
when DMSO was used (Entry 1), while 34% yield and 20% e.e were found when acetone 
was used (Entry 2). A very poor yield of 3% and 16% e.e was obtained in DCM (Entry 3), 
and using chloroform the highest e.e of 43% was found but with a poor yield of 15% (Entry 
4). On the other hand, for the methyl ester 167, the highest e.e that we had was 28% using 
acetone which also gave the highest yield of 76% (Entry 2). A very poor yield of 9% and 5% 
e.e were seen when DCM was used (Entry 3), while using chloroform gave 28% yield and 
25% e.e (Entry 4) (Table 37). 
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After we had evaluated all our α-amino catalysts, we tested the β-amino catalysts in the 
Mannich reaction. We began with the β-carboxylic acids 133 and 156 using the same 
conditions and solvents. 
Unfortunately all the attempts failed, with only starting materials obtained (Table 38).   
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After the failure of the β-carboxylic acids, we tested the methyl ester catalyst 161. Starting 
with DMSO, only starting material was obtained (Entry 1), but using acetone gave 39% yield 
with 22% e.e (Entry 2). A decrease of the yield using DCM of 27% yield was observed as 
well as a huge drop in the e.e to 3% (Entry 3). Lastly, a poor yield of 13% and 11% e.e were 
found when chloroform was used (Entry 4) ( Table 39).   
 
 
After we had tested all the α-and β-amino catalysts, we chose the best conditions that we had 
found, which were the α-ethyl ester 166 with chloroform (Entry 4, Table 37) and the α-
methyl ester  167 with acetone (Entry 2, Table 37), and tested them with several aldehydes. 
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The ethyl ester catalyst 166 gave a poor yield with isovaleraldehyde and a disappointing e.e 
of 7% (Entry 1). Only starting material was observed when isobutyraldehyde used (Entry 3). 
Unfortunately, only starting material was obtained when 2-napthaldehyde and both halogen 
benzaldehydes the bromo and the fluoro were used (Entry 2, 4 and 5). However, with the 
methyl ester catalyst 167, when isovaleraldehyde was used a moderate yield of 43% but a 
very poor e.e of 6% was obtained (Entry 1). Isobutyraldehyde gave a poor yield of 26% but 
the highest e.e of 45% (Entry 3). As with the ethyl ester catalyst, no Mannich product was 
obtained when 2-napthaldehyde and both halogen benzaldehydes the bromo and the fluoro 
were used (Entry 2, 4 and 5) (Table 40). 
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Unfortunately, results for both aldol and Mannich reactions were poor, and after investigation 
we think that the low acidity of the carboxylic acid group could be the reason after a 
comparison with several amino acid catalysts. In the L-proline, 2-piperidinecarboxylic acid 
176, and 177 the values of the carboxylic acid pKa were 2.0, 2.5 and 2.5 respectively. In 
addition, the less acidic pKa in β-alanine 178 and 179 of 3.6 and 4.0 respectively.35, 36 
Therefore, this may indicate that a more acidic group may be required for these reactions to 
be catalysed efficiently (Figure 16). 
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7.0 Conclusion 
Synthesis of new axially chiral aminocatalysts was the target of our project, motivated from 
the excellent results that L-proline has delivered. Starting with synthesis of the α-carboxylic 
acids from BINOL in a six step procedure with a key of lithiation/carboxylation step gave 
both α-acid diastereomeric catalysts were obtained. Products 174 and 175 were obtained in 
12% and 15% yields overall respectively (Scheme 62).     
 
In addition, we have synthesised the corresponding binaphthyl α-ethyl 166 and the methyl 
167 ester amino acids (Scheme 63). 
 
97 
 
Moreover, to assess the effect of adding a carbon atom between the amino and the carboxylic 
acid groups we successfully synthesised the β-binaphthyl carboxylic acids 133 and 156, in 
addition to the β-methyl ester 161, over an 8-step process for the acids and 7-steps for the 
methyl ester, including a Reformatsky addition. The overall yield of 133 was 22%, and, for 
the bulkier acid 156 was 12%. Lastly, the overall yield of the methyl ester 161 was 22% 
(Scheme 64). 
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8.0 Future work 
Further modification in our design of catalysts to be more complex in order to reach higher 
enantioselectivities, as in many successful catalysts, would be desirable (Figure 16). 
Following Maruoka who tried to improve his catalyst to be more nucleophilic by introduction 
of electron-donating groups on the ring as in catalyst 82.37 Including of more acidic groups 
instead of the carboxylic acid such as the triflamide groups 180. Adding both electron-donating 
group and acidic groups (such trifamide) to provide more acidic groups (than the carboxylic 
groups) and more nucleophilic amines 181 (Figure 17).38, 39, 40, 41 
 
 
 
Catalyst synthesis might be achieved using the same methods that we used before. Starting 
with 146, NBS oxidation and diastereoselective nucleophilic Grignard addition to provide 
182, followed by allyl/Boc deprotection and protection step to give 183. Asymmetric 
lithiation and addition of chloroformate, and finally deprotection of the Boc group, to give the 
improved catalyst 185, which should be more nucleophilic caused by the effect of the 
donating group (iso-propane) (Scheme 65). 
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Chapter three: Experimental section 
 IR spectres were recorded on a Perkin-Elmer 100 FT-IR spectrophotometer and samples 
were used as thin film DCM solutions on KBr plates, melting points were recorded using a 
Büchi B-545 Melting Point apparatus. NMR spectra were recorded on a Bruker 500 MHz 
Spectrometer. Chemical shifts were recorded in parts per million (ppm), J values are given in 
Hertz (Hz) and are referenced against tetramethylsilane (TMS) or the residual deuterated 
solvents peak. Optical rotations were obtained using a Bellingham and Stanley Ltd ADP440 
polarimeter and the solvents used for these measurements were of HPLC-grade quality. 
High-resolution mass spectra were obtained from the EPSRC Mass Spectrometry Unit at 
the University of Swansea. Enantiomeric excesses were determined by chiral high 
performance liquid chromatography using a Hitachi Elite LaChrom HPLC system using an L-
2200 autosampler, L-2130 pump and L-2400 UV detector. All HPLC samples were run 
against racemate as a standard and using a hexane-isopropanol mixture. Conditions varied 
and are provided in detail below.  
Unless otherwise stated, all starting materials were sourced from commercial suppliers and 
were used without any purification. Reactions which required the use of anhydrous solvents 
were, in the case of THF and Et2O, dried and distilled over sodium and benzophenone. DCM 
and CH3CN were distilled over CaH2 and DMF was distilled over MgSO4. Needles and 
glassware were oven-dried were and allowed to cool under a positive pressure of nitrogen gas 
prior to use. Light petroleum ether was distilled at 40-60 °C to remove impurities. 
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1.0 Synthesis of azepines 
(S)-[1,1’]-Binaphthalene-2,2’-diol bis-trifluoromethanesulfonate 1341 
 
 
(S)-[1,1]-2-2’-Binaphthalene diol (10.00 g, 35 mmol) and 4-dimethylaminopyridine ( 1.71 g 
14 mmol, 0.4 equiv.) were dissolved in dry dichloromethane  ( 250 mL) and the reaction was 
cooled to -78°C. 2, 6- Lutidine (12.2 mL, 104 mmol, 3.0 equiv.) and trifluromethanesulfonic 
anhydride (18.0 mL, 104 mmol, 3.0 equiv.) were added to the reaction. The reaction mixture 
turned from yellow to pink and was allowed to reach room temperature overnight. The reaction 
mixture during this time turned from pale pink to dark brown. Silica gel was added (~10 g) and 
the solvent was evaporated under reduced pressure. The silica gel was washed with petroleum 
ether (around 2 L) in a sintered funnel. The petroleum ether fractions were mixed and the 
solvent removed under reduced pressure to yield the title compound as a colorless solid (18.6 
g, 96% )  without further purification. 
m.p. 85-86 °C [Lit 86-88 °C]
1
; [α]D
24.0 
+146  (c=1.00, CHCl3), ( Lit [α]D
22.5
 +144), (c 1.00, 
CHCl3)
1; ν
max 
(CH2Cl2)/cm
-1  3065, 1592, 1509, 1423, 1216, 1139, 1066, 963, 940, 703, 768, 
750, 656; 1H NMR (500 MHz, CDCl3) δ 8.18 (d, J = 9.0 Hz, 2H), 8.05 (d, J = 8.3 Hz, 2H), 7.67 
(d, J = 9.1 Hz, 2H), 7.63 (ddd, J = 8.1, 6.8, 1.1 Hz, 2H), 7.45 (ddd, J = 8.2, 6.8, 1.2 Hz, 2H), 
7.33 – 7.28 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 145.3, 133.1, 132.3, 131.9, 128.3, 127.9, 
127.3, 126.7, 123.4, 119.3. 116.9. 
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(S)-2,2'-Dimethyl-[1,1']binaphthalene 1351 
 
 
 
(S)-[1,1’]-Binaphthalene-2,2’-diol-bis-trifluoromethanesulfonate (16.26 g, 29.5 mmol) and 
1,3-bis(diphenylphosphino)propane nickel (II) chloride (1.11 g, 2.06 mmol, 0.07 equiv.) were 
dissolved in dry Et2O (300ml). The reaction mixture was cooled to -78 °C and solution of 
methyl magnesium bromide (3M in Et2O, 39.3 mL, 118.1 mmol, 4.0 equiv.) was added slowly 
and the reaction left to reach room temperature overnight. H2O (around 50 mL) wa added at 0 
°C to quench the excess of Grignard reagent and the reaction was diluted with Et2O (100 mL) 
and left for 30 min to stir. The mixture was filtered over a plug of Celite® and washed with 
Et2O (around 50 mL) and the filtrate was transferred to separating funnel and the organic layer 
was washed with H2O (4 x 50 mL) and a brine (2 x 30 mL), dried over anhydrous MgSO4 and 
filtered. The solvents were evaporated under reduced pressure. The mixture was recrystallized 
with hot methanol to yield the title compound as colorless crystals (7.9 g, 94%). 
m.p. 76–78 °C (Lit 75–77 °C)1, [α]D24.0 +35.5 (c 1.00, CHCl3), (Lit [α]D22.5 +36.5), (c 1.00, 
CHCl3)
 1; ν
max 
(CH2Cl2)/cm-1 3051, 3008,2856, 1442, 1507, 1421, 1352, 1221 1027; 
1H NMR 
(500 MHz, CDCl3) δ 7.91 (d, J = 8.0 Hz, 2H), 7.89 (d, J = 8.1 Hz, 2H) 7.51 (d, J = 8.4 Hz, 2H), 
7.40 (ddd, J = 8.1, 6.8, 1.1 Hz, 2H), 7.21 (ddd, J = 8.2, 6.8, 1.2 Hz, 2H), 7.05 (d, J = 8.4 Hz, 
2H), 2.04 (s, 6H). 13C  NMR (126 MHz, CDCl3) δ 135.1, 134.3, 132.7, 132.2, 128.7, 127.9, 
127.4, 126.1, 125.6, 124.9, 20.0. 
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(S)-2,2’-Bis-bromomethyl-[1,1’]binaphthalene 1362 
 
 
 
(S)-2,2’-Dimethyl [1,1’] binaphthalene (2.50 g, 8.85 mmol), N-bromosuccinimide (3.93 g, 22.1 
mmol, 2.5 equiv.) and azobisisobutyronitrile (0.14 g, 0.88 mmol, 0.1 equiv.) were dissolved in 
cyclohexane (14 mL, 14 % w/v solution). The mixture was heated at reflux 4 h until completion 
was observed using TLC. The reaction was cooled to 0 °C and EtOAc (4 mL, 1/3 of the volume 
of cyclohexane) and distilled water (28 mL, double the volume of cyclohexane) were added. 
The reaction was stirred for 1 h to allow for precipitation and filtration to give the title 
compound as a yellow solid (2.84 g, 73%).  
m.p. 183-185 °C (Lit 188-190 °C)1 , [α]D23.5 -173.9  (c 1.00, CHCl3), (Lit [α]D22.5 -174.4), (c 
1.00, CHCl3)
1;  ν
max 
(CH2Cl2)/cm-1 3050, 2978, 2315, 1693, 1433, 1211, 851, 754, 725; 
1H 
NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.6 Hz, 2H), 7.93 (d, J = 8.2 Hz, 2H), 7.75 (d, J = 8.6 
Hz, 2H), 7.49 (ddd, J = 8.1, 6.8, 1.1 Hz, 2H), 7.30 – 7.26 (m, 2H), 7.08 (d, J = 7.9 Hz, 2H), 
4.26 (s, 4H); 13C NMR (126 MHz, CDCl3) δ 134.21, 134.11, 133.29, 132.53, 129.39, 128.05, 
127.77, 126.87, 126.84, 126.81, 32.6. 
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(S)-Allyl-4,5-dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a']dinaphthalene 1373 
 
 
 (S)-2,2’-Bis-(bromomethyl)-[1-1’]-binaphthalene (1.50 g, 3.40 mmol) and allylamine (0.27 
mL, 3.74 mmol, 1.1 equiv.) were dissolved in acetonitrile (20 mL). Potassium carbonate 
anhydrous (1.40.98 g, 10.2 mmol, 3.0 equiv.) was added to the mixture and heated at reflux 
overnight or until completion was observed using TLC. The reaction mixture was cooled to 
room temperature and diluted with dichloromethane (30 mL) and filtered to remove potassium 
carbonate. The filtrate was transferred to a separating funnel and the organic layer washed with 
H2O (3  x 10 mL), a brine (2  x 20 mL) and dried over anhydrous MgSO4 and filtered. The 
solvent was removed under reduced pressure giving an orange solid. Recrystallization (hot 
acetone) yielding the title compound as a pale yellow solid (0.97 g, 85%).  
m.p. 166-168 °C (Lit 167-169 °C)1, [α]D23.0 +399.1  (c 1.80, CHCl3) (Lit [α]D22.5  +396.2  (c 
1.80, CHCl3)
1; ν
max 
(CH2Cl2)/cm-1 3414, 3051, 2923, 2802, 263, 2492, 2296, 1508, 1423, 1163, 
880, 822; 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.3 Hz, 4H), 7.56 (d, J = 8.2 Hz, 2H), 7.52 
– 7.44 (m, 4H), 7.27 (ddd, J = 6.8, 4.9, 1.3 Hz, 2H), 6.07 – 5.97 (m, 1H), 5.28 (dd, J = 16.9, 
1.8 Hz, 1H), 5.28 (dd, J = 10.5, 1.0 Hz, 1H), 3.76 (d, J = 12.4 Hz, 2H), 3.18 (d, J = 12.4 Hz, 
2H), 3.16 – 3.09 (m, 2H); 13C  NMR (126 MHz, CDCl3) δ 136.4, 135.2, 133.5, 133.3, 131.6, 
128.5, 128.4, 127.9, 127.6, 125.9, 125.6, 118.1, 58.6, 55.0. 
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(S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide1 
 
 
 
(S)-Allyl-4,5-dihydro-3H-4-aza-cyclohepta[2,1-a;3,4-a']dinaphthalene (1.40 g, 4.17 mmol) 
Was dissolved in dichloromethane (70 mL). The flask was placed in an ice bath and N-
bromosuccimide (0.77 g, 4.37 mmol, 1.05 equiv.) was added and the reaction was stirred for 1 
h or until completion was observed using TLC. The solvent was removed under reduced 
pressure to yield the crude bromide salt as an orange foamy solid (4.21 g crude mass, not 
routinely isolated). 
 m.p.105-107°C (Lit m.p.* 110 °C(*decomp), [α]
D
23.5
+317.4  (c 1.00, CHCl3) (Lit. [α]D
22.5 
+316.0  (c 1.00, CHCl3)
1; ν
max 
(CH2Cl2)/cm
-1 
3657, 3469, 3053, 2891, 2386, 1772, 1708, 1650, 
1508, 1428, 1350, 1179, 1062; 1H NMR (500 MHz, CDCl3) δ 10.84 (1H, s), 8.47 (1H, d, J= 
8.5 Hz), 8.13 (1H, d, J= 8.6 Hz), 8.09 (1H, d, J= 8.3 Hz), 8.04 (1H, d, J= 8.4 Hz), 7.92 (1H, d, 
J= 8.3 Hz), 7.74 (1H, ddd, J= 8.2, 6.6, 1.0 Hz), 7.62 (1H, d, J= 8.4 Hz), 7.52–7.48 (2H, m,), 
7.37 (1H, m), 7.25 (1H, ddd, J= 8.2, 6.7, 1.1 Hz), 7.07-7.06 (1H, d, J= 8.3 Hz), 5.95 (1H, m,), 
5.70 (1H, d, J= 16.8 Hz), 5.53 (1H, d, J= 10.7 Hz), 5.34 (1H, dd, J= 14.5, 6.7 Hz), 5.20 (1H, 
dd, J= 14.0, 6.5 Hz), 5.01 (1H, d, J= 13.2 Hz), 4.51 (1H, d, J= 13.1 Hz); 13C NMR (126 MHz, 
CDCl3) δ 177.6, 170.0, 141.3, 135.6, 134.8, 133.8, 132.0, 131.5, 131.4, 130.4, 129.6, 129.5, 
128.7, 128.5, 127.7, 127.4, 127.3, 127.3, 127.2, 127.0, 125.4, 125.1, 63.6, 56.4, 30.1  
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(S)-4-Allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate 1461 
 
 
 
Crude (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium bromide (4.21 g) was dissolved in 
a minimum volume of ethanol. In another flask sodium tetraphenylborate (1.56 g, 4.58  mmol, 
1.1 equiv.) was dissolved in minimum volume of acetonitrile and combined with the first 
solution. The solution was stirred for 10 min. A bright yellow precipitate formed immediately. 
The solid was filtered and washed with cold ethanol to yield the title compound as a yellow 
solid and dried at 70 °C overnight (5.29 g, 79%). 
 m.p.* 158 °C (Lit. m.p.* 160 °C (*decomp.)1, [α]D23 +409.7  (c 1.00, MeCN), (Lit. [α]D22.5 
+410.5  (c 1.00, MeCN)1; ν
max 
(CH2Cl2)/cm
-1 
3054, 2998, 2672, 2397, 2315, 1709, 1508, 1265, 
1150, 817; 1H NMR (500 MHz, DMSO) δ 9.57 (s, 1H), 8.40 (d, J = 8.4 Hz, 1H), 8.27 (t, J = 
8.7 Hz, 2H), 8.10 (dd, J = 14.5, 8.3 Hz, 2H), 7.87 (d, J = 8.4 Hz, 1H), 7.81 (t, J = 7.7 Hz, 1H), 
7.57 (t, J = 7.6 Hz, 1H), 7.51 (t, J = 7.5 Hz, 1H), 7.45 (d, J = 8.0 Hz, 1H), 7.32 (t, J = 7.6 Hz, 
1H), 7.19 (s, 8H), 7.00 (d, J = 8.6 Hz, 1H), 6.94 (t, J = 7.4 Hz, 8H), 6.80 (t, J = 7.2 Hz, 4H), 
6.01 – 5.92 (m, 1H), 5.67 (d, J = 18.4 Hz, 1H), 5.55 (d, J = 10.1 Hz, 1H), 5.16 (d, J = 13.5 Hz, 
1H), 4.86 (d, J = 4.7 Hz, 2H), 4.71 (d, J = 13.7 Hz, 1H); 13C NMR (126 MHz, DMSO) δ 180.0, 
164.3, 164.1, 163.5, 163.1, 141.2, 136.9, 136.2, 135.1, 133.4, 131.8, 131.5, 131.3, 131.2, 130.8, 
129.8, 129.6, 129.6, 129.2, 128.5, 127.7, 127.3, 126.9, 126.7, 125.8, 125.8, 125.8, 125.7, 124.3, 
123.2, 63.3 
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2.0 Synthesis of of β-amino acids and derivatives 
tert-Butyl-2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]-azepin-3yl) acetate 1514 
 
Zinc dust (2.29 g, 35.1 mmol, 10 equiv.) and TMSCl (0.44mL, 3.51 mmol, 1 equiv.) were 
added to anhydrous THF (50 mL) in a flame-dried nitrogen-purged round-bottom flask. The 
reaction was heated to reflux for 30 min. Tert-butyl bromoacetate (0.51 mL, 3.51 mmol, 1 
equiv.) was added and the reaction was heated to reflux for a further 30 min. The reaction was 
cooled to –78 °C. (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium tetraphenylborate (2.30 
g, 3.51 mmol) was dissolved in anhydrous THF (50 mL) in separate flame-dried round-bottom 
flask and then transferred into the zinc solution at –78 °C by using a cannula. The mixture was 
stirred at –78 °C for 1 h and t-butyl bromoacetate (5.18 ml, 35.1 mmol, 10 equiv.) was added 
in small portions over 15 to 20 min. Reaction was allowed to reach the room temperature and 
monitored by TLC. The reaction was quenched using a saturated ammonium chloride solution 
(10 mL), Et2O (60 mL) was added and the mixture filtered through a pad of Celite
®. The filtrate 
was transferred to a separating funnel and the organic layer washed with H2O (3 x 20 mL), 
brine (3 x 20 mL), and dried over anhydrous MgSO4 and filtered. The solvent was removed 
under reduced pressure to give a yellow oil. The product was purified using column 
chromatography on silica gel (12:1 light petoleum ether/ EtOAc) to yield the title compound 
as a colourless oil (1.09 g, 68%) 
m.p. 93-95 °C (Lit. m.p. 92-94)1, [α]D23.5 +158.6  (c 1.00, CHCl3) (Lit. [α]D22.4 +158), (c 1.00, 
CHCl3)
1; ν
max 
(CH2Cl2)/cm-1 3050, 2976, 1725, 1507, 1366, 1246, 1149, 819; 
1H NMR (500 
MHz, CDCl3) δ 7.97 – 7.91 (m, 4H), 7.63 (d, J = 8.3 Hz, 1H), 7.48 – 7.41 (m, 4H), 7.36 (d, J 
= 8.1 Hz, 1H), 7.27 – 7.22 (m, 2H), 6.01 – 5.92 (m, 1H), 5.25 (dd, J = 17.1, 1.6 Hz, 1H), 5.19 
(d, J = 10.1 Hz, 1H), 4.41 (d, J = 11.1 Hz, 1H), 3.69 (d, J = 11.4 Hz, 1H), 3.33 – 3.22 (m, 2H), 
3.08 (d, J = 10.9 Hz, 1H), 1.72 (dd, J = 15.1, 7.1 Hz, 1H), 1.50 (dd, J = 15.1, 8.4 Hz, 1H), 1.15 
(s, 9H); 13C NMR (126 MHz, CDCl3) δ 171.3, 136.1, 135.5, 135.2, 135.0, 133.5, 133.3, 133.0, 
131.9, 131.8, 130.0, 129.0, 128.4, 128.3, 128.1, 128.0, 127.6, 127.4, 125.9, 125.7, 125.6, 125.6, 
118.0, 79.9, 64.1, 61.4, 56.1, 42.6, 27.9 
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Tert-Butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl) acetate 1551 
 
 
 
Tert-Butyl 2-((3S,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetate 
(1.70 g, 3.78 mmol) was dissolved in anhydrous dichloromethane (70 mL). Pd(PPh3)4 (0.08 
g, 0.07 mmol, 0.02 equiv.) and 1,3-dimethylbarbituric acid (1.77 g, 11.34 mmol, 3 equiv.) were 
added and the reaction slowly heated to reflux overnight or until full consumption of the 
starting material was observed by TLC. The reaction was allowed to reach room temperature 
and the solvent was removed under reduced pressure and the residue was redissolved in Et2O 
(60 mL) and transferred to a separating funnel. The organic layer was washed with 1 M NaOH 
solution ( 2 x 20 mL), H2O ( 2 x 20 mL), brine (20 mL), dried over anhydrous MgSO4 and 
filtered. After the filtration, the solvent was removed under reduced pressure and the residue 
was purified using column chromatography on silica gel (6:4 light petroleum ether/EtOAc) to 
yield the title compound as a pale yellow foam (1.27 g, 82%). 
m.p. 75-77 °C (Lit. m.p. 78-79 °C)1; [α]D23.1 +205.1  (c 1.00, CHCl3), (Lit [α]D22.4 +206), (c 
1.00, CHCl3)
1; ν
max 
(CH2Cl2)/cm-1 3054, 2981, 1719, 1509, 1436, 1366, 1301, 1217, 1147, 
1116, 819;1H NMR (500 MHz, CDCl3) δ 7.95 (dt, J = 14.6, 7.4 Hz, 4H), 7.58 (d, J = 8.3 Hz, 
1H), 7.52 (d, J = 8.4 Hz, 1H), 7.48 – 7.43 (m, 2H), 7.40 (d, J = 8.6 Hz, 1H), 7.34 (d, J = 8.5 
Hz, 1H), 7.26 – 7.21 (m, 2H), 4.62 (t, J = 7.6 Hz, 1H), 3.79 (d, J = 12.1 Hz, 1H), 3.72 (d, J = 
12.1 Hz, 1H), 1.77 (dd, J = 15.0, 7.5 Hz, 1H), 1.70 (dd, J = 15.0, 7.7 Hz, 1H), 1.18 (s, 9H); 13C 
NMR (126 MHz, CDCl3) δ 171.4, 137.4, 136.6, 134.9, 133.8, 133.1, 133.0, 132.0, 129.2, 129.0, 
128.8, 128.3, 128.1, 127.4, 127.3, 126.9, 125.8, 125.6, 125.6, 125.4, 80.1, 60.4, 59.1, 48.7, 
42.9, 27.9. 
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2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetic acid 1331 
 
 
 
Tert-Butyl 2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl) acetate (0.419 g, 
1.02 mmol) was dissolved in dichloromethane (20 mL) and trifluoroacetic acid ( 0.93 mL, 
12.24 mmol, 12 equiv.) was added. The mixture was stirred until consumption of the starting 
material was observed by TLC. A saturated sodium hydrogen carbonate solution was added 
until the pH of the solution was neutral. The mixture was transferred to a separating funnel and 
the organic layer washed with H2O (10 mL), brine (2 x 10 mL) and dried over anhydrous 
MgSO4 and filtered. After the filtration, the solvent was removed under reduced pressure and 
the residue recrystallized (CH2Cl2 and light petroleum ether) to yield the title compound as a 
white solid (0.332 g, 91%). 
 m.p. 224-226 °C (Lit. m.p. 228–230 °C)1; [α]D22.3 +261.8  (c 1.00, CHCl3) (Lit. [α]D22.4 +264  
(c 1.00, CHCl3)
1; ν
max 
(CH2Cl2)/cm-1 3390, 3053, 2968, 1682, 1595, 1392, 1200, 1121, 821; 
1H NMR (500 MHz, DMSO) δ 8.08 (d, J = 8.3 Hz, 2H), 8.05 (d, J = 8.3 Hz, 2H), 7.70 (d, J = 
8.3 Hz, 1H), 7.60 (d, J = 8.5 Hz, 1H), 7.55 – 7.49 (m, 2H), 7.34 – 7.27 (m, 2H), 7.24 (d, J = 
8.7 Hz, 1H), 7.16 (d, J = 8.6 Hz, 1H), 4.63 (dd, J = 10.1, 5.6 Hz, 1H), 3.93 (d, J = 11.9 Hz, 
1H), 3.50 (d, J = 12.0 Hz, 1H), 1.70 (dd, J = 16.1, 5.5 Hz, 1H), 1.28 (dd, J = 15.8, 4.8 Hz, 1H); 
13C NMR (126 MHz, DMSO) δ 175.8, 136.7, 135.1, 133.3, 133.2, 133.2, 131.9, 131.8, 131.7, 
129.6, 129.4, 129.3, 129.0, 128.7, 127.9, 126.9, 126.8, 126.8, 126.8, 126.5, 126.3, 56.9, 46.4, 
38.8. 
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Tert-Butyl-2-((3R,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3yl)-2-
methylpropanoate 1581 
 
Zinc dust (1.19 g, 18.3 mmol, 10 equiv.) and TMSCl (0.23 mL, 1.83 mmol, 1 equiv.) added to 
anhydrous THF (30 mL) in a flame-dried nitrogen-purged round-bottom flask. The reaction 
was heated to reflux for 30 min. tert-Butyl α-bromoisobutyrate (0.34 mL, 1.83 mmol, 1 equiv.) 
was added and the reaction was refluxed for a further 30 min. The reaction was cooled to –78 
°C. The (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium (1.2 g, 1.83 mmol) was dissolved 
in anhydrous THF (30 mL). In separate flame-dried round-bottom flask and then transferred 
into the zinc solution at –78 °C by using a cannula. The mixture was stirred at –78 °C for 1 h 
and tert-Butyl α-bromoisobutyrate (3.41 ml, 18.3 mmol, 10 equiv.) was added in small portions 
over 15 to 20 min. The reaction allowed to reach the room temperature and monitored by TLC. 
The reaction was quenched using a saturated ammonium chloride solution (5 mL), Et2O (50 
mL) was added and the mixture filtered through a pad of Celite®. The filtrate was transferred 
to a separating funnel and the organic layer washed with H2O ( 3 x 20 mL), brine (3 x 20 mL), 
and dried over anhydrous MgSO4 filtered. After the filtration, the solvent was removed under 
reduced pressure to give a yellow oil. The product was purified using column chromatography 
on silica gel (12:1 light petoleum ether/ EtOAc) to yield the title compound as a colourless oil 
(0.65 g, 74%) (NB: inseparable impurities) 
 m.p. 118-120 °C (Lit. m.p. 118-115 °C); [α]D21.8 +102.1  (c 1.0, CHCl3) [α]D18.9 +102.8  (c 1.3, 
CHCl3); νmax (CHCl3)/cm-1 3051, 2977, 2934, 1713, 1458, 1469, 1367, 1253, 1168, 1035, 918, 
753, 673; 1H NMR (400 MHz, CDCl3) δ 7.92 – 7.85 (m, 4H), 7.54 (d, J = 8.3 Hz, 1H), 7.46 – 
7.39 (m, 3H), 7.37 (d, J = 8.6 Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 7.24 – 7.19 (m, 1H), 7.19 – 
7.14 (m, 1H), 6.00 – 5.85 (m, 1H), 5.27 – 5.18 (m, 1H), 5.17 – 5.08 (m, 1H), 4.55 (s, 1H), 3.65 
(d, J = 11.3 Hz, 1H), 3.51 – 3.45 (m, 2H), 3.41 (d, J = 11.3 Hz, 1H), 1.29 (s, 9H), 0.43 (s, 3H), 
0.29 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 176.9, 136.4, 136.0, 135.9, 135.7, 134.1, 133.0, 
132.9, 132.7, 132.2, 128.6, 128.3, 128.2, 128.1, 127.9, 127.7, 127.5, 125.8, 125.6, 125.3, 125.1, 
117.1, 81.7, 80.3, 79.7, 64.5, 55.1, 51.0, 27.9, 22.4, 22.3. 
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Tert-Butyl-2-((3R,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methylpropanoate 1591 
 
Tert-Butyl-2-((3R,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methylpropanoate (1.3 g, 2.72 mmol) was dissolved in anhydrous dichloromethane (80 mL). 
Pd(PPh3)4 (0.05 g, 0.05 mmol, 0.02 equiv.) and 1,3-Dimethylbarbituric acid (1.27 g, 8.16 
mmol, 3 equiv.) were added and the reaction slowly heated to reflux overnight or until full 
consumption of the starting material was observed by TLC. The reaction was allowed to reach 
room temperature and the solvent was removed under reduced pressure and the residue was 
redissolved in Et2O (70 mL) and transferred to a separating funnel. The organic layer was 
washed with 1 M NaOH solution (2 x 20 mL), H2O (2 x 20 mL), brine (2 x 20 mL), dried over 
anhydrous MgSO4 filtered. After the filtration, the solvent was removed under reduced pressure 
and the residue was purified using column chromatography on silica gel (1:1 light petroleum 
ether/EtOAc) to yield the title compound as a pale yellow foam ( 0.71 g, 60%). 
m.p. 91-93 °C (Lit. m.p. 87-89 °C)1; [α]D22.3 +316.7  (c 1.00, CHCl3) (Lit. [α]D20.1 +314.0  (c 
1.00, CHCl3)
1; ν
max 
(CH2Cl2)/cm-1 3057, 2974, 2929, 2414, 1725, 1609, 1507, 1464, 1388, 
1366, 1249, 1139, 1113, 1080, 849, 820; 1H NMR (500 MHz, CDCl3) δ 7.88 (dd, J = 8.3, 4.5 
Hz, 4H), 7.50 (d, J = 8.3 Hz, 1H), 7.45 (d, J = 8.5 Hz, 1H), 7.44 – 7.37 (m, 2H), 7.26 (d, J = 
7.3 Hz, 2H), 7.20 (ddd, J = 9.4, 5.3, 2.0 Hz, 1H), 7.14 (ddd, J = 9.6, 5.4, 2.1 Hz, 1H), 4.89 (s, 
1H), 3.95 (d, J = 12.6 Hz, 1H), 3.73 (d, J = 12.7 Hz, 1H), 1.38 (s, 9H), 0.73 (s, 3H), 0.23 (s, 
3H); 13C NMR (126 MHz, CDCl3) δ 176.7, 139.0, 136.1, 134.8, 134.6, 133.4, 132.8, 132.8, 
132.7, 132.4, 128.7, 128.3, 128.1, 127.8, 127.7, 127.4, 126.6, 125.8, 125.6, 125.3, 124.9, 80.0, 
70.3, 50.7, 49.3, 28.0, 23.6, 19.5. 
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2-((3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-methylpropanoic 
acid 1561 
 
 
Tert-Butyl-2-((3R,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)-2-
methylpropanoate ( 0.230 g, 0.52 mmol) was dissolved in dichloromethane (20 mL) and 
trifluoroacetic acid ( 0.47 mL, 6.24 mmol, 12 equiv.) was added. The mixture was stirred until 
consumption of the starting material was observed by TLC. A saturated sodium hydrogen 
carbonate solution was added until pH of the solution was neutral. The mixture was transferred 
to a separating funnel and the organic layer washed with H2O (20 mL), brine ( 2 x 10 mL), 
dried over anhydrous MgSO4 filtered. After the filtration, the solvent was removed under 
reduced pressure and the residue recrystallized (CHCl3 and light petroleum ether) to yield the 
title compound as a white solid (0.124 g, 62%). 
m.p. 189-191 °C (Lit. m.p. 192-194 °C)1; [α]D22.6 +140.4 (c 1.0, CHCl3) [α]D24.9 +138.1 (c 0.9, 
CHCl3)
1; ν
max 
(CH2Cl2)/cm-1 3417, 3057, 2974, 2846, 1675, 1598, 1470, 1200, 1135, 821, 749; 
1H NMR (500 MHz, CDCl3) δ 7.95 (dd, J = 16.9, 9.3 Hz, 2H), 7.85 (d, J = 8.2 Hz, 1H), 7.80 
(d, J = 8.2 Hz, 1H), 7.60 – 7.43 (m, 4H), 7.26 – 7.20 (m, 4H), 7.18 (d, J = 7.7 Hz, 1H), 5.32 (s, 
1H), 4.17 (d, J = 13.0 Hz, 1H), 3.96 (d, J = 12.7 Hz, 1H), 1.00 (s, 3H), -0.11 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 179.6, 136.1, 133.8, 133.8, 133.4, 132.8, 132.4, 131.7, 131.4, 129.5, 
129.4, 129.2, 128.7, 128.1, 128.0, 127.6, 127.4, 126.8, 126.6, 126.3, 126.1, 77.0, 67.7, 47.2, 
27.6, 26.2. 
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Methyl 2-((3R,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetate 
160 
 
Zinc dust (1.49 g, 22.9 mmol, 10 equiv.) and TMSCl (0.29 mL, 2.29 mmol, 1 equiv.) were 
added to anhydrous THF (30 mL) in  a flame-dried nitrogen-purged round-bottom flask. The 
reaction was heated to reflux for 30 min. Methyl chloroacetate (0.20 mL, 2.29 mmol, 1 equiv.) 
was added and the reaction was heated to reflux for a further 30 min. The reaction was cooled 
to –78 °C. The (S)-4-allyl-3H-dinaphtho[2,1-c:1',2'-e]azepin-4-ium (1.50 g, 2.29 mmol) was 
dissolved in anhydrous THF (30 mL) in a separate flame-dried round-bottom flask and then 
transferred into the zinc solution at –78 °C  using a cannula. The mixture was stirred at –78 °C   
for 1 h and methyl chloroacetate (2.0 ml, 22.9 mmol, 10 equiv.) was added in small portions 
over 15 to 20 min. The reaction allowed to reach the room temperature and monitored by TLC. 
The reaction was quenched using a saturated ammonium chloride solution (5 mL), Et2O (40 
mL) was added and the mixture filtered through a pad of Celite®. The filtrate was transferred 
to a separating funnel and the organic layer washed with H2O (3 x 10 mL), brine (3 x 10 mL), 
and dried over anhydrous MgSO4 and filtered. After the filtration, the solvent was removed 
under reduced pressure to give a yellow oil. The product was purified using column 
chromatography on silica gel (12:1 light petoleum ether/ EtOAc) to yield the title compound 
as a colourless oil (0.746, 79%) 
m.p. 127-128  °C [α]D
23.8
+245.3 (c 1.00, CH2Cl2); νmax (CH2Cl2)/cm
-1 
3051, 2977, 2948, 
1734, 1507, 1435, 1265, 1173, 820;
 1H NMR (500 MHz, DMSO) δ 8.09 – 8.03 (m, 4H), 7.68 
(d, J = 8.3 Hz, 1H), 7.50 (ddd, J = 8.5, 5.7, 4.0 Hz, 3H), 7.33 – 7.30 (m, 1H), 7.30 – 7.27 (m, 
2H), 7.19 (d, J = 8.5 Hz, 1H), 5.93 – 5.84 (m, 1H), 5.24 (dd, J = 17.2, 1.7 Hz, 1H), 5.16 (dd, J 
= 10.2, 1.8 Hz, 1H), 4.43 (dd, J = 8.6, 6.5 Hz, 1H), 3.70 (d, J = 10.9 Hz, 1H), 3.30 (s, 3H), 3.26 
(dd, J = 13.9, 5.9 Hz, 1H), 3.19 (dd, J = 13.8, 7.1 Hz, 1H), 2.92 (d, J = 10.8 Hz, 1H), 1.61 (dd, 
J = 15.6, 6.4 Hz, 1H), 1.50 (dd, J = 15.7, 8.7 Hz, 1H);13C NMR (126 MHz, DMSO) δ 171.7, 
136.5, 135.4, 135.3, 135.1, 133.0, 131.5, 129.8, 129.4, 129.0, 128.9, 128.7, 128.4, 126.9, 126.8, 
126.5, 126.4, 126.2, 126.1, 118.1, 63.3, 61.2, 55.4, 51.3, 40.9; HRMS (NSI+) m/z found for 
[M+H]+: 408.1958; [C28H25NO2]+ requires 408.1958. 
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Methyl 2-((3R,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetate 161 
 
 
 
Methyl-2-((3R,11cS)-4-allyl-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-3-yl)acetate 
(0.320g, 0.785 mmol) was dissolved in anhydrous dichloromethane (30 mL). Pd(PPh3)4 (0.017 
g, 0.015 mmol, 0.02 equiv.) and 1,3-dimethylbarbituric acid ( 0.366 g, 2.35 mmol, 3 equiv.) 
were added and the reaction slowly heated to reflux overnight or until full consumption of the 
starting material was observed by TLC. The reaction was allowed to reach room temperature 
and the solvent was removed under reduced pressure and the residue was redissolved in Et2O 
(30 mL) and transferred to a separating funnel. The organic layer was washed with 1 M NaOH 
solution (2 x 10 mL), H2O ( 2 x 10 mL), brine (10 mL), dried over anhydrous MgSO4 and 
filtered. After the filtration, the solvent was removed under reduced pressure and the residue 
was purified using column chromatography on silica gel (1:1 light petroleum ether/EtOAc,) to 
yield the title compound as a pale yellow foam ( 0.182 g, 63%). 
m.p. 86-88 °C; [α]D
23.8 
+342.8  (c 1.00, CHCl3); νmax (CH2Cl2)/cm
-1 
3338, 3049, 2948, 2842, 
1732, 1506, 1435, 1263, 821; 1H NMR (500 MHz, DMSO) δ 8.08 – 8.01 (m, 4H), 7.65 (d, J = 
8.3 Hz, 1H), 7.54 (d, J = 8.4 Hz, 1H), 7.51 – 7.46 (m, 2H), 7.32 – 7.25 (m, 2H), 7.23 (d, J = 
8.2 Hz, 1H), 7.16 (d, J = 8.5 Hz, 1H), 4.58 (dd, J = 8.3, 6.7 Hz, 1H), 3.73 (d, J = 11.5 Hz, 1H), 
3.41 (d, J = 11.5 Hz, 1H), 3.30 (s, 3H), 1.69 (dd, J = 15.5, 6.6 Hz, 1H), 1.59 (dd, J = 15.5, 8.5 
Hz, 1H); 13C NMR (126 MHz, DMSO) δ 171.9, 137.0, 134.8, 133.2, 133.0, 131.8, 129.4, 129.3, 
129.2, 128.8, 128.7, 127.9, 126.8, 126.4, 126.3, 126.0, 125.9, 58.1, 51.3, 48.2, 41.6; HRMS 
(NSI+) m/z found for [M+H]+: 368.1649; [C25H21NO2]+ requires 368.1645. 
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3.0 Synthesis of α-amino acid and derivatives   
(S)-Tert-Butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate 1631 
 
 
 
(S)-2,2’-Bis-bromomethyl-[1,1’]binaphthalene (600 mg, 1.36 mmol) was dissolved in 
anhydrous DMF (35 mL). The yellow solution was cooled to 0 °C, and NaH (130 mg, 5.45 
mmol, 4 equiv.) was added in one portion. t-Butyl carbamate (160 mg, 1.36 mmol, 1 equiv.) 
was added slowly to the solution. The reaction mixture was stirred for 4 days or until full 
consumption of the starting material was seen by TLC and it was observed the colour of 
solution changed to a pale pink. The reaction was quenched by addition of ammonium chloride 
(15 mL) at 0 °C and the solvent was removed under reduced pressure. Et2O (110 mL) was 
added to the mixture and the organic layer washed with H2O (4 x 15 mL), brine (3 x 15 mL), 
dried over anhydrous MgSO4 and filtered. After the filtration, recrystallization with hot acetone 
yielding the title compound as a colourless solid (469 mg, 87%).   
m.p. 220-222 °C (Lit. m.p. 219- 221 °C)1; [α]D18.4 −11.0 (c 1.00, CHCl3); (Lit.  [α]D22.5 −7.0  (c 
1.00, CHCl3)
1; ν
max 
(CH2Cl2)/cm
-1 
3051, 2976, 2930, 2869, 1922, 1687, 1508, 1463, 1402, 
1365, 1274, 1251, 1216, 1162, 1103, 906, 858, 818; 1H NMR (500 MHz, CDCl3) δ 8.03 – 7.93 
(m, 4H), 7.62 (d, J = 8.3 Hz, 2H), 7.48 (ddd, J = 8.1, 6.7, 1.1 Hz, 2H), 7.43 (dd, J = 8.5, 0.6 
Hz, 2H), 7.30 – 7.25 (m, 2H), 4.93 (br s, 2H), 3.64 (d, J = 12.5 Hz, 2H), 1.51 (s, 9H); 13C NMR 
(126 MHz, CDCl3) δ 154.4, 135.0, 133.3, 133.2, 131.5, 129.1, 128.3, 127.5, 127.4, 126.0, 
125.7, 84.0, 79.9, 28.5, 27.3 
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(3R,11cS)-4-Tert-Butyl 3-ethyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)dicarboxylate 
1641 
 
 
(S)-Tert-Butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate (0.965 g, 2.43 mmol) 
was dissolved in Et2O (80 mL) at -78 °C. Sec-BuLi (2.42 mL, 3.15 mmol, 1.3 equiv., 1.3 M in 
cyclohexane) was added dropwise causing the pale yellow solution to turn black and left for 1 
h. Ethyl chloroformate (0.69 mL, 7.29 mmol, 3 equiv.) was added in one portion, the solution 
turn from black to bright yellow. The reaction was allowed to reach room temperature 
overnight or until full consumption of the starting material was observed by TLC. The reaction 
was quenched with saturated ammonium chloride solution (20 mL) at 0 °C. The organic layer 
was washed with H2O (3 x 40 mL), brine (3 x 40 mL), dried over anhydrous MgSO4 and 
filtered. After the filtration, the solvent removed under reduced pressure. The crude product 
was purified using column chromatography on silica gel (7:3 light petroleum ether/EtOAc) 
yielding the title compound as a colourless solid (0.803 g, 70%) 
m.p. 97-99 °C (Lit. m.p. 101-103 °C)1; [α]D21.7 −19.2  (c 1.00, CHCl3) (Lit. [α]D22.1 −17.6 (c 
1.00, CHCl3)
1; ν
max 
(CH2Cl2)/cm
-1 
3053, 2977, 2933, 1745, 1697, 1476, 1456, 1392, 1313, 
1250, 1217, 1156, 916, 863; 1H NMR (500 MHz, DMSO at 360 K) δ 8.02 (d, J = 8.2 Hz, 1H), 
7.96 (m, 2H), 7.89 (d, J = 8.2 Hz, 1H), 7.68 – 7.62 (m, 1H), 7.58 – 7.47 (m, 2H), 7.46 – 7.39 
(m, 2H), 7.33 (dd, J = 8.5, 3.3 Hz, 1H), 7.30 – 7.27 (m, 1H), 7.25 – 7.21 (m, 1H),  5.69 (s, 1H), 
5.03 (d, J = 13.3 Hz, 1H), 3.64 (d, J = 13.4 Hz, 1H), 3.09 – 3.02 (m, 1H), 2.83 – 2.74 (m, 1H), 
1.47 (s, 9H), 0.47 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 170.05, 169.63, 154.26, 
154.06, 134.87, 134.46, 134.32, 134.0, 133.42, 133.4, 133.21, 133.17, 133.15, 131.78, 131.56, 
131.35, 129.76, 129.38, 129.28, 128.83, 128.51, 128.25, 128.11, 127.86, 127.6, 127.3, 127.3, 
127.12, 126.30, 126.25, 126.28, 126.07, 126.02, 125.8, 125.6, 80.6, 80.6, 62.3, 61.1, 60.8, 60.7, 
47.8, 46.7, 28.4, 28.3, 13.5, 13.2. 
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(3R,11cS)-Ethyl 4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylate 1661 
 
 
 
(3R,11cS)-4-Tert-butyl 3-ethyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-dicarboxylate 
(0.720 g, 1.53 mmol) was dissolved in dichloromethane (30 mL). Trifluoroacetic acid (1.63 
mL, 21.42 mmol, 14 equiv.) was added and the reaction was stirred until consumption of the 
starting material was observed by TLC. Saturated sodium hydrogen carbonate solution was 
added until the pH of the solution was neutral. The solvent was removed under reduced pressure 
and the residue redissolved in EtOAc (20 mL). The organic layer was washed with H2O (3 x 
20 mL), brine (3 x 20 mL) and dried over anhydrous MgSO4 and filtered. After filtration, the 
solvent was removed under reduced pressure and the residue purified by column 
chromatography on silica gel (EtOAc), giving the title compound as a yellow solid (0.481 g, 
85%). 
 
m.p. 119-201 °C; [α]
D
21.4  
+379.2  (c 1.00, CHCl3), (Lit. [α]D
23.1 
+386.0  (c 1.00, CHCl3)
1    ; 
ν
max 
(CH2Cl2)/cm
-1 
3316, 3050, 2979, 2869, 1724, 1463, 1222, 1205, 1110, 912, 813; 1H NMR 
(500 MHz, CDCl3) δ 8.03 (d, J = 8.3 Hz, 1H), 7.96 (m, 2H), 7.90 (d, J = 8.2 Hz, 1H), 7.67 (d, 
J = 8.3 Hz, 1H), 7.54 – 7.47 (m, 2H), 7.45 – 7.36 (m, 3H), 7.29 – 7.23 (m, 2H), 4.68 (s, 1H), 
3.91 (d, J = 13.7 Hz, 1H), 3.59 (d, J = 13.7 Hz, 1H), 3.29 – 3.19 (m, 1H), 2.64 – 2.55 (m, 1H), 
0.50 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 173.2, 134.8, 133.5, 133.4, 133.0, 
133.0, 131.5, 131.5, 129.7, 129.1, 129.1, 128.8, 128.3, 128.3, 127.3, 127.2, 126.9, 126.0, 125.9, 
125.5, 125.5, 62.2, 61.2, 48.1, 13.2. 
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(3R,11cS)-4-Tert-butyl 3-methyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-
3,4(5H)dicarboxylate 1651 
 
 
 
(S)-Tert-Butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate (1.60 g, 4.04 mmol) was 
dissolved in Et2O (80 mL) at -78 °C. sec-BuLi (4.03 mL, 5.25 mmol, 1.3 equiv., 1.3 M in 
cyclohexane) was added dropwise causing the pale yellow solution to turn black and the 
mixture was left for 1 h. Methyl chloroformate (0.938 mL, 12.12 mmol, 3equiv.) was added in 
one portion, the solution turned from black to bright yellow. The reaction was allowed to reach 
room temperature overnight or until full consumption of the starting material was observed by 
TLC. The reaction was quenched with saturated ammonium chloride solution (40 mL) at 0 °C. 
The organic layer was washed with H2O ( 3 x 30 mL), brine (3 x 30 mL), dried over anhydrous 
MgSO4 and filtered. After the filtration, the solvent removed under reduced pressure. The crude 
product was purified using column chromatography on silica gel (9:1 light petroleum 
ether/EtOAc) yielding the title compound as a colourless solid (1.471 g, 80%) 
m.p. 121-123 °C (Lit. m.p. 124-126 °C)1; [α]D19.2 −17.3  (c 0.5, CHCl3), (Lit. [α]D22.6  −20.8  (c 
0.5, CHCl3))
1; ν
max 
(CH2Cl2)/cm
-1 
3052, 2975, 2947, 2880, 1751, 1695, 1508, 1456, 1391, 
1366, 1296, 1155, 953, 822; 1H NMR (500 MHz, DMSO at 380 K) δ 8.14 (1H, d, J= 8.2 Hz), 
8.08 (1H, d, J= 8.3 Hz), 8.05 (1H, d, J= 8.3 Hz), 8.01 (1H, d, J= 8.1 Hz), 7.82 (1H, d, J= 8.4 
Hz), 7.63 (1H, d, J= 8.4 Hz), 7.58 (1H, ddd, J= 8.2, 6.7, 1.3 Hz), 7.53 (1H, ddd, J= 8.2, 6.7, 1.2 
Hz), 7.39-7.34 (1H, m), 7.31–7.25 (2H, m), 7.11 (1H, d, J= 8.5 Hz), 5.67 (1H, s), 5.08 (1H, d, 
J= 12.9 Hz), 3.57 (1H, d, J= 13.1 Hz), 2.44 (3H, s), 1.48 (9H, s); 13C NMR (126 MHz, DMSO 
at 380 K) δ 168.9, 151.2, 136.8, 136.8, 134.6, 134.3, 134.3, 133.4, 133.2, 132.4, 130.7, 129.3, 
128.9, 128.6, 128.3, 128.3, 127.6, 127.4, 126.4, 126.2, 126.0, 125.9, 125.5, 83.7, 77.2, 77.0, 
49.0, 28.1, 28.0. 
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(3R,11cS)-Methyl 4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylate 1671 
 
 
 
(3R,11cS)-4-Tert-butyl 3-methyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-3,4(5H)-dicarboxylate 
(1.00 g, 2.20 mmol) was dissolved in dichloromethane (20 mL). Trifluoroacetic acid (2.35 mL, 
30.8 mmol, 14 equiv.) was added and the reaction was stirred until consumption of the starting 
material was observed by TLC. Saturated sodium hydrogen carbonate solution was added until 
the pH of the solution was neutral. The solvent was removed under reduced pressure and the 
residue redissolved in EtOAc (50 mL). The organic layer was washed with H2O (3 x 30 mL), 
brine (3 x 30 mL), dried over anhydrous MgSO4 and filtered. After the filtration, the solvent 
removed under reduced pressure and recrystallized (CHCl3 and light petroleum ether) giving 
the title compound as a white solid (0.637 g, 81%). 
m.p. 213-215 °C (Lit. m.p. 214-216 °C)1 ; [α]D22.1 +432.5  (c 1.0, CHCl3), (Lit. [α]D21.4 +420  (c 
1.03, CHCl3))
1; ν
max 
(CH2Cl2)/cm
-1 
3314, 3051, 2948, 2870, 1730, 1507, 1432, 1222, 1205, 
1112, 991, 866, 821; 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 8.2 Hz, 1H), 7.99 – 7.94 (m, 
2H), 7.91 (d, J = 8.2 Hz, 1H), 7.64 (d, J = 8.3 Hz, 1H), 7.52 – 7.48 (m, 2H), 7.44 – 7.41 (m, 
2H), 7.36 (d, J = 8.5 Hz, 1H), 7.30 – 7.27 (m, 1H), 7.25 – 7.23 (m, 1H), 4.64 (s, 1H), 3.86 (d, 
J = 13.7 Hz, 1H), 3.58 (d, J = 13.7 Hz, 1H), 2.49 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 174.0, 
137.1, 133.5, 133.4, 133.4, 132.9, 131.5, 131.4, 129.7, 129.1, 128.4, 128.3, 128.3, 127.2, 127.0, 
126.8, 126.1, 126.0, 126.0, 125.5, 62.1, 51.7, 48.3. 
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(11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine3-
carboxylic acid synthesis 
 
 
 
(S)-Tert-Butyl 3H-dinaphtho[2,1-c:1',2'-e]azepine-4(5H)-carboxylate (1.00 g, 2.52 mmol) was 
dissolved in anhydrous Et2O (60 mL) at -78 °C. sec-Buli (2.51 mL, 3.27 mmol, 1.3 equiv., 1.3 
M in cyclohexane) was added causing the solution turn from pale yellow to black and the 
reaction was stirred for 1 h. CO2 gas was bubbled directly into the solution via a drying tube. 
The reaction was stirred until consumption of the starting material was observed by TLC. The 
reaction was quenched at 0 °C with ammonium chloride (15 mL) and EtOAc (30 mL) was 
added. The organic layer was washed with H2O ( 2 x 20 mL), dried over anhydrous Na2SO4 
and the solvent removed under reduced pressure. 
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The first diastereoisomer: 
(3S,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'e]azepine-3-
carboxylic acid 1711 
 
 
Purification by column chromatography on silica gel (EtOAc), isolated as a colourless solid 
(0.34 g, 30%) 
m.p. 247-249 °C (Lit. m.p. 255-257 °C)1; [α]D20.9 +56.7  (c 1.00, CHCl3) (Lit. [α]D23.9 +58.4 (c 
1.00, CHCl3)
1; ν
max 
(CHCl3)/cm-1 3054, 3001, 2972, 1750, 1725, 1697, 1401, 1367, 1251, 
1220, 1150, 820; 1H NMR (500 MHz, DMSO, VT NMR at 353 K)  δ 8.11 – 7.78 (m, 4H), 7.66 
(d, J = 6.7 Hz, 1H), 7.62 – 7.36 (m, 4H), 7.35 – 7.26 (m, 2H), 7.23 (d, J = 8.4 Hz, 1H), 5.00 (d, 
J = 15.3 Hz, 1H), 4.69 (s, 1H), 3.73 (d, J = 13.7 Hz, 1H), 1.46 (s,  9H). 
13C NMR (126 MHz, DMSO, VT NMR at 353 K)  δ 171.2, 136.5, 133.4, 133.2, 131.7, 131.5, 
130.5, 129.7, 129.4, 129.2, 128.9, 128.3, 128.3, 128.2, 127.5, 126.4, 126.3, 126.2, 125.9, 125.8, 
125.3, 124.2, 79.9, 61.9, 45.9, 28.2. 
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The Second diastereoisomer: 
(3R,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'e]azepine-3-
carboxylic acid 1721 
 
 
Purification by column chromatography on silica gel (4:1 light petroleum ether/ EtOAc), 
isolated as a colourless solid (0.38 g, 34 %) 
 m.p. 174-176 °C (Lit. m.p. 164-167 °C)1; [α]D21.3  −44.9  (c 1.00, CHCl3) (Lit. [α]D23.9 −47.2  
(c 1.00, CHCl3)
1; ν
max 
(CHCl3)/cm-1 3053, 2981, 1754, 1395, 1366, 1300, 1244, 1156, 913, 
820; 1H NMR (500 MHz, DMSO, VT NMR at 363 K)  δ 8.01 (d, J = 8.3 Hz, 1H), 7.95 (d, J = 
8.2 Hz, 1H), 7.92-7.90 (m, 2H), 7.61 (d, J = 8.3 Hz, 1H), 7.55 (d, J = 8.1 Hz, 1H), 7.49 (ddd, 
J = 10.4, 5.7, 2.4 Hz, 1H), 7.43 (ddd, J = 8.1, 6.7, 1.2 Hz, 1H), 7.37 (d, J = 8.5 Hz, 1H), 7.27 
(dd, J = 7.5, 1.9 Hz, 1H), 7.25 (d, J = 3.2 Hz, 1H), 7.22 – 7.16 (m, 1H), 5.89 (s, 1H), 5.02 (d, J 
= 14.8 Hz, 1H), 3.67 (d, J = 14.3 Hz, 1H), 1.52 (s, 9H); 13C NMR (126 MHz, DMSO, VT at 
363 K) δ 170.6, 154.3, 134.7, 133.9, 131.7, 131.7, 129.4, 129.3, 128.6, 128.6, 128.4, 127.7, 
127.2, 126.4, 126.1, 126.1, 80.4, 62.7, 48.4, 28.5. 
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By product: 
(S)-Tert-Butyl ((2'-formyl-[1,1'-binaphthalen]-2-yl)methyl)carbamate 173 
 
 
 
Eluted first in on silica gel (4:1 light petroleum ether/EtOAc) as colourless oil (0.13 g, 12%). 
m.p. 123-125 °C; [α]D22.4 +4.2  (c 0.5, CHCl3), (Lit. [α]D23.7 +6.0  (c 0.5, CHCl3); νmax 
(CH2Cl2)/cm-1 3351, 3060, 3000, 2979, 2932, 1763, 1695 1603, 1507, 1461, 1430, 1401, 1367, 
1320, 1231, 1168, 1023, 855, 819; 1H NMR (500 MHz, CDCl3) δ 9.58 (s, 1H), 8.16 (d, J = 8.6 
Hz, 1H), 8.07 – 8.02 (m, 2H), 7.98 (d, J = 8.2 Hz, 1H), 7.94 (d, J = 8.0 Hz, 1H), 7.72 (d, J = 
8.5 Hz, 1H), 7.61 (t, J = 7.5 Hz, 1H), 7.47 (t, J = 7.5 Hz, 1H), 7.34 (ddd, J = 8.2, 6.8, 1.2 Hz, 
1H), 7.29 – 7.26 (m, 1H), 7.24 (d, J = 8.8 Hz, 1H), 7.02 (d, J = 8.5 Hz, 1H), 4.54 (s, 1H), 4.02 
(d, J = 5.8 Hz, 2H), 1.36 (s, 9H).13C NMR (126 MHz, CDCl3) δ 191.9, 155.6, 142.7, 136.3, 
136.2, 133.7, 132.5, 132.6, 132.3, 129.4, 129.2, 129.0, 128.6, 128.1, 127.5, 127.0, 126.9, 126.2, 
125.9, 122.3, 79.7, 42.8, 28.3, 28.1. 
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(3S,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylic acid 1741 
 
 
 
(3S,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-
carboxylic acid (0.970 g, 2.20 mmol) was dissolved in dichloromethane (15 mL), 
Trifluoroacetic acid (2.35 mL, 30.8 mmol, 14 equiv.) was added. The reaction was stirred for 
30 min, a saturated solution of sodium hydrogen carbonate was added to neutralised the pH of 
the solution. The solvent was removed under reduced pressure and the residue redissolved in 
EtOAc (15 mL). The organic layer was washed with H2O (3 x 10 mL), brine ( 3 x 10 mL), 
dried over anhydrous MgSO4 and filtered. After the filtration, the solvent removed under 
reduced pressure and the residue was recrystallized (CHCl3 and light petroleum ether) giving 
the title compound (0.533 g, 71%). 
 
m.p. 271-273 °C (Lit. m.p. 276-280 °C)1; [α]D19.3 +191.7  (c 1.00, CHCl3), [α]D24.5 +196.0  (c 
1.00, CHCl3); νmax (CH2Cl2)/cm-1 3384, 3055, 2995, 2961, 2586, 1724, 1633, 1397, 1370 1344, 
1194, 1139, 1036, 821, 749; 1H NMR (500 MHz, DMSO) δ 8.14 (ddd, J = 20.9, 10.5, 6.1 Hz, 
4H), 7.72 (d, J = 8.3 Hz, 2H), 7.59 (dt, J = 9.2, 7.6 Hz, 2H), 7.44 – 7.39 (m, 1H), 7.38 – 7.34 
(m, 1H), 7.31 (d, J = 8.5 Hz, 1H), 7.23 (d, J = 8.5 Hz, 1H), 4.12 (d, J = 13.1 Hz, 1H), 3.83 (s, 
1H), 3.37 (d, J = 13.0 Hz, 1H); 13C NMR (126 MHz, DMSO) δ 170.4, 135.2, 135.1, 133.7, 
133.6, 131.2, 130.8, 129.5, 129.2, 129.1, 129.0, 128.9, 128.5, 127.2, 127.1, 127.0, 126.9, 126.8, 
126.8, 126.7, 126.6, 60.2, 45.9. 
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(3R,11cS)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-carboxylic acid 175  1 
 
 
 
(3R,11cS)-4-(Tert-butoxycarbonyl)-4,5-dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepine-3-
carboxylic acid (0.320 g, 0.72 mmol) was dissolved in dichloromethane (10 mL), 
Trifluoroacetic acid (0.77 mL, 10.08 mmol, 14 equiv.) was added. The reaction was stirred for 
30 min and a saturated solution of sodium hydrogen carbonate was added to neutralise the pH 
of the solution. The solvent was removed under reduced pressure and the residue redissolved 
in EtOAc (10 mL). The organic layer was washed with H2O (3 x 5 mL), brine (3 x 5 mL), dried 
over anhydrous MgSO4 and filtered. After the filtration, the solvent removed under reduced 
pressure and the residue was recrystallized (CHCl3 and light petroleum ether) giving the title 
compound (0.200 g, 80%). 
 
m.p. 270-272 °C (Lit. m.p. 269-271 °C)1; [α]D23.5  +274.1  (c 1.00, CHCl3), (Lit. [α]D24.5 +272.8 
(c 1.00, CHCl3); νmax (CH2Cl2)/cm-1 3394, 3053, 2593, 1719, 1636, 1370, 1201, 1134, 820, 
750; 1H NMR (500 MHz, DMSO) δ 8.21 (d, J = 8.4 Hz, 1H), 8.13 (dd, J = 8.3, 2.9 Hz, 2H), 
8.07 (d, J = 8.2 Hz, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 8.4 Hz, 1H), 7.58 (dt, J = 17.9, 
7.4 Hz, 2H), 7.36 (t, J = 7.6 Hz, 2H), 7.17 (dd, J = 8.4, 5.0 Hz, 2H), 5.47 (s, 1H), 4.29 (d, J = 
13.1 Hz, 1H), 3.63 (d, J = 13.0 Hz, 1H).13C NMR (126 MHz, DMSO) δ 168.8, 134.7, 134.5, 
133.9, 133.7, 131.4, 131.2, 131.2, 131.1, 130.7, 129.9, 129.9, 129.8, 128.9, 128.9, 128.5, 127.5, 
127.2, 127.1, 126.8, 126.6, 60.7, 45.4 
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4.0 Aldol examples procedure5 
(4R)-(4-Nitrophenyl)-4-hydroxy-2-butanone 
 
 
L-proline (0.0045 g, 0.035 mmol, 0.035 equiv.) was added to a mixture of acetone (0.2 mL, 2.7 
mmol, 27 equiv.) and dimethyl sulfoxide (0.8 mL) and the mixture stirred for 15 min. 4-
Nitrobenzaldehyde ( 0.015 g, 0.1 mmol) was added and the reaction stirred overnight or until  
the starting material was consumed as indicated by TLC. The mixture was treated with 
saturated aqueous ammonium chloride solution (1 mL) and the solvent removed under the 
reduced pressure and the residue was redissolved in EtOAc and washed with H2O (1 mL), brine 
(1 mL) and dried over MgSO4 and filtered. After the filtration, the solvent was removed under 
reduced pressure and the residue was purified by column chromatography on silica gel (3:1 
light petroleum ether/EtOAc) giving the title compound as a colourless solid (0.014 g, 68%). 
[α]D
25.5 
+42.7  (c 1.00, CHCl3)
6 ; ν
max 
(CH2Cl2)/cm
-1 
3419, 2921, 2851, 1711, 1518, 1346, 
1163, 1076, 856; 1H NMR (400 MHz, CDCl3) δ 8.13 – 8.08 (m, 2H), 7.47 – 7.38 (m, 2H), 5.16 
(dd, J = 8.2, 4.1 Hz, 1H), 3.44 (s, 1H), 2.77 – 2.68 (m, 2H), 2.11 (s, J = 4.4 Hz, 3H); 13C NMR 
(126 MHz, CDCl3) δ 208.5, 149.8, 126.4, 124.0, 123.8, 68.9, 51.5, 30.7. 
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(4R)-(3-Nitrophenyl)-4-hydroxy-2-butanone 
 
 
 
L-proline (0.0045 g, 0.035 mmol, 0.035 equiv.) was added to a mixture of acetone (0.2 mL, 2.7 
mmol, 27 equiv.) and dimethyl sulfoxide (0.8 mL) and the mixture stirred for 15 min. 3-
Nitrobenzaldehyde (0.015 g, 0.1 mmol) was added and the reaction stirred overnight or until 
the starting material was consumed as indicated by TLC. The mixture was treated with 
saturated aqueous ammonium chloride solution (1 mL) and the solvent removed under the 
reduced pressure and the residue was redissolved in EtOAc and washed with H2O (1 mL), brine 
(1 mL) and dried over MgSO4 and filtered. After the filtration, the solvent was removed under 
reduced pressure and the residue was purified by column chromatography on silica gel (3:1 
light petroleum ether/EtOAc) giving the title compound as a colourless solid (0.0109 g, 52%). 
 
[α]D
25.5 
+43.2  (c 1.00, CHCl3)
7; ν
max 
(CH2Cl2)/cm
-1 
3423, 2923, 2851, 1709, 1528, 1350, 
1164, 1068, 808; 1H NMR (500 MHz, CDCl3) δ 8.24 (q, J = 1.8 Hz, 1H), 8.14 (ddd, J = 8.2, 
2.3, 1.0 Hz, 1H), 7.73 – 7.69 (m, 1H), 7.53 (t, J = 7.9 Hz, 1H), 5.26 (dd, J = 8.0, 4.1 Hz, 1H), 
3.61 (s, 1H), 2.93 – 2.83 (m, 2H), 2.23 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 208.6, 131.8, 
129.5, 122.6, 120.7, 68.8, 51.5, 30.7. 
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(4R)-(3-Bromophenyl)-4-hydroxy-2-butanone 
 
 
 
 
L-proline (0.0045 g, 0.035 mmol, 0.035 equiv.) was added to a mixture of acetone (0.2 mL, 2.7 
mmol, 27 equiv.) and dimethyl sulfoxide (0.8 mL) and the mixture stirred for 15 min. 4-
bromobenzaldehyde ( 0.0185 g, 0.1 mmol) was added and the reaction stirred overnight or until  
the starting material was consumed as indicated by TLC. The mixture was treated with 
saturated aqueous ammonium chloride solution (1 mL) and the solvent removed under the 
reduced pressure and the residue was redissolved in EtOAc and washed with H2O (1 mL), brine 
(1 mL) and dried over MgSO4 and filtered. After the filtration, the solvent was removed under 
reduced pressure and the residue was purified by column chromatography on silica gel (3:1 
light petroleum ether/EtOAc) giving the title compound as white solid (0.018 g, 74%). 
[α]D
25.5 
+42.9  (c 1.00, CHCl3)
8; ν
max 
(CH2Cl2)/cm
-1 
3417, 2920, 2851, 1712, 1487, 1361, 
1162, 1070, 828, 538; 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.43 (m, 2H), 7.26 – 7.22 (m, 2H), 
5.12 (dd, J = 8.2, 4.0 Hz, 1H), 3.34 (s, 1H), 2.87 – 2.76 (m, 2H), 2.20 (s, 3H); 13C NMR (126 
MHz, CDCl3) δ 208.9, 141.7, 131.6, 127.3, 121.4, 69.2, 51.7, 30.7. 
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(4R)-(2-naphthyl)-4-hydroxy-2-butanone 
 
 
 
L-proline (0.0045 g, 0.035 mmol, 0.035 equiv.) was added to a mixture of acetone (0.2 mL, 2.7 
mmol, 27 equiv.) and dimethyl sulfoxide (0.8 mL) and the mixture stirred for 15 min. 2-
naphthaldehyde ( 0.0156 g, 0.1 mmol) was added and the reaction stirred overnight or until  the 
starting material was consumed as indicated by TLC. The mixture was treated with saturated 
aqueous ammonium chloride solution (1 mL) and the solvent removed under the reduced 
pressure and the residue was redissolved in EtOAc and washed with H2O (1 mL), brine (1 mL) 
and dried over MgSO4 and filtered. After the filtration, the solvent was removed under reduced 
pressure and the residue was purified by column chromatography on silica gel (3:1 light 
petroleum ether/EtOAc) giving the title compound as a colourless solid (0.0114 g, 53%). 
[α]D
25.5 
-34.6  (c 1.00, CHCl3); )
9; ν
max 
(CH2Cl2)/cm
-1 
3463, 2921, 2858, 1708, 1488, 1361, 
1164, 1064, 820;  1H NMR (500 MHz, CDCl3) δ 7.87 – 7.80 (m, 4H), 7.51– 7.44 (m, 3H), 5.33 
(dd, J = 8.9, 3.1 Hz, 1H), 3.37 (s, 1H), 3.01 – 2.88 (m, 2H), 2.22 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 209.1, 140.0, 133.3, 132.9, 128.4, 128.0, 127.7, 126.2, 125.9, 124.3, 123.7, 70.0, 
51.9, 30.8. 
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(4R)-(4-phenyl)-4-hydroxy-2-butanone 
 
 
 
L-proline (0.0045 g, 0.035 mmol, 0.035 equiv.) was added to mixture of acetone (0.2 mL, 2.7 
mmol, 27 equiv.) and dimethyl sulfoxide (0.8 mL) and the mixture stirred for 15 min. 
Benzaldehyde (0.010 mL, 0.1 mmol) was added and the reaction stirred overnight or until  the 
starting material was consumed as indicated by TLC. The mixture was treated with saturated 
aqueous ammonium chloride solution (1 mL) and the solvent removed under the reduced 
pressure and the residue was redissolved in EtOAc and washed with H2O (1 mL), brine ( 1 mL) 
and dried over MgSO4 and filtered. After the filtration, the solvent was removed under reduced 
pressure and the residue was purified by column chromatography on silica gel (3:1 light 
petroleum ether/EtOAc) giving the title compound as white solid (0.010g, 62%). 
 
 
[α]D
25.5 
+ 19.7  (c 1.00, CHCl3)
10; ν
max 
(CH2Cl2)/cm
-1 
3431, 2920, 2850, 1712, 1515, 1361, 
1163, 1061, 843; 1H NMR (500 MHz, CDCl3) δ 7.37 (dd, J = 9.5, 2.4 Hz, 4H), 7.36 – 7.26 (m, 
1H), 5.18 (d, J = 8.9 Hz, 1H), 3.38 (s, J = 8.6 Hz, 1H), 2.92 (dd, J = 17.5, 9.2 Hz, 1H), 2.83 
(dd, J = 17.5, 3.2 Hz, 1H), 2.22 (s, J = 1.3 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 209.1, 
142.7, 128.5, 127.7, 125.6, 69.8, 51.9, 30.7. 
  
 
 
 
 
 
134 
 
(4R)-(4-methoxyphenyl)-4-hydroxy-2-butanone 
 
 
 
 
L-proline (0.0045 g, 0.035 mmol, 0.035 equiv.) was added to mixture of acetone (0.2 mL, 2.7 
mmol, 27 equiv.) and dimethyl sulfoxide (0.8 mL) and the mixture stirred for 15 min. 4-
Methoxybenzaldehyde ( 0.0121 mL, 0.1 mmol) was added and the reaction stirred overnight 
or until  the starting material was consumed as indicated by TLC. The mixture was treated with 
saturated aqueous ammonium chloride solution (1 mL) and the solvent removed under the 
reduced pressure and the residue was redissolved in EtOAc and washed with H2O (1 mL), brine 
( 1 mL) and dried over MgSO4 and filtered. After the filtration, the solvent was removed under 
reduced pressure and the residue was purified by column chromatography on silica gel (3:1 
light petroleum ether/EtOAc) giving the title compound as a colourless oil (0.0129 g, 66%). 
[α]D
23.1
+38.6  (c 1.00, CHCl3)
8; ν
max 
(CH2Cl2)/cm
-1 
3444, 2957, 2837, 1710, 1514, 1361, 
1248, 1031, 834; 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.26 (m, 2H), 6.90 – 6.86 (m, 2H), 5.11 
(dt, J = 9.3, 3.0 Hz, 1H), 3.80 (s, 3H), 3.17 (d, J = 3.1 Hz, 1H), 2.89 (dd, J = 17.5, 9.3 Hz, 1H), 
2.79 (dd, J = 17.4, 3.2 Hz, 1H), 2.19 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 209.1, 159.1, 
134.9, 126.9, 113.9, 69.5, 55.3, 51.9, 30.7. 
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5.0 Mannich examples reaction.11 
(4S)-4-[(4-Methoxyphenyl)amino]-4-(4-nitrophenyl)-2-butanone 
 
 
 
L-proline (0.40 g, 0.35 mmol, 0.35 equiv.)), p-anisidine (0.135, 1.1 mmol, 1.1 equiv.) and 4-
nitrobenzaldehyde (0.151 g, 1 mmol) were dissolved in DMSO/acetone (4:1, 10 mL). The 
reaction was stirred at room temperature overnight or until the starting material was consumed 
as indicated by TLC. The mixture was extracted with phosphate-buffered saline (PBS) solution 
(pH 7.4) and ethyl acetate. The organic layer was dried with MgSO4, filtered, the solvent 
removed under reduced pressure and the residue purified by column chromatography with (2:1 
light petroleum  ether/ ethyl acetate), giving the title compound as a yellow oil ( 0.136 g, 43%). 
ν
max 
(CH2Cl2)/cm
-1
 3418, 2923, 2851, 1645, 1510, 1244, 1032; 1H NMR (500 MHz, CDCl3) δ 
8.19 – 8.15 (m, 2H), 7.58 – 7.53 (m, 2H), 6.71 – 6.66 (m, 2H), 6.48 – 6.45 (m, 2H), 4.85 (t, J 
= 6.3 Hz, 1H), 3.69 (s, 3H), 2.95 (d, J = 6.2 Hz, 2H), 2.15 (s, 3H); 13C NMR (126 MHz, CDCl3) 
δ 206.0, 153.7, 150.5, 147.2, 141.6, 127.4, 124.0, 115.5, 114.8, 114.8, 55.6, 54.7, 54.7, 50.6, 
30.7. 
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(4S)-4-[(4-Methoxyphenyl)amino]-4-(2-naphthyl)-2-butanone 
 
L-proline (0.40 g, 0.35 mmol, 0.35 equiv.)), p-anisidine (0.135, 1.1 mmol, 1.1 equiv.) and 4-
nitrobenzaldehyde (0.156 g, 1 mmol) were dissolved in DMSO/acetone (4:1, 10 mL). The 
reaction was stirred at room temperature overnight or until the starting material was consumed 
as indicated by TLC. The mixture was extracted with phosphate-buffered saline (PBS) solution 
(pH 7.4) and ethyl acetate. The organic layer was dried with MgSO4, filtered, the solvent 
removed under reduced pressure and the residue purified by column chromatography with (2:1 
light petroleum  ether/ ethyl acetate), giving the title compound as a white solid (0.097 g, 30%). 
ν
max 
(CH2Cl2)/cm
-1
 3409, 2919, 2832, 1708, 1510, 1238, 1035, 817; 1H NMR (500 MHz, 
CDCl3) δ 7.82 – 7.78 (m, 4H), 7.50 – 7.44 (m, 3H), 6.69 – 6.65 (m, 2H), 6.57 – 6.53 (m, 2H), 
4.92 (t, J = 6.5 Hz, 1H), 3.67 (s, 3H), 3.00 – 2.96 (m, 2H), 2.12 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 207.1, 152.4, 149.7, 140.9, 140.2, 133.4, 128.7, 127.9, 127.6, 126.1, 125.8, 125.1, 
124.4, 115.4, 114.7, 55.6, 55.5, 51.3, 30.7. 
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(4R)-4-[(4-Methoxyphenyl)amino]-6-methyl-2-heptanone 
 
 
L-proline (0.40 g, 0.35 mmol, 0.35 equiv.)), p-anisidine (0.135, 1.1 mmol, 1.1 equiv.) and 
Isovaleraldehyde (0.109 mL, 1 mmol) were dissolved in DMSO/acetone (4:1, 10 mL). The 
reaction was stirred at room temperature overnight or until the starting material was consumed 
as indicated by TLC. The mixture was extracted with phosphate-buffered saline (PBS) solution 
(pH 7.4) and ethyl acetate. The organic layer was dried with MgSO4, filtered, the solvent 
removed under reduced pressure and the residue purified by column chromatography with (2:1 
light petroleum  ether/ ethyl acetate), giving the title compound as a yellow oil (0.217 g, 87%). 
ν
max 
(CH2Cl2)/cm
-1
 3378, 2955, 2927, 1709, 1510, 1464, 1243, 1035, 825; 1H NMR (500 MHz, 
CDCl3) δ 6.78 – 6.75 (m, 2H), 6.60 – 6.56 (m, 2H), 3.79 (ddd, J = 13.0, 8.0, 4.9 Hz, 1H), 3.74 
(s, 3H), 2.66 (dd, J = 16.4, 5.0 Hz, 1H), 2.58 – 2.51 (m, 1H), 2.12 (s, 3H), 1.74 (qd, J = 13.1, 
6.6 Hz, 1H), 1.47 (ddd, J = 14.2, 8.2, 6.2 Hz, 1H), 1.33 (ddd, J = 13.7, 8.0, 5.7 Hz, 1H), 0.93 
(d, J = 6.7 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 208.6, 152.4, 
141.8, 115.1, 114.9, 55.9, 49.3, 48.2, 44.8, 31.1, 25.1, 23.1, 22.4. 
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(4S)-4-[(4-Methoxyphenyl)amino]-5-methyl-2-hexanone 
 
L-proline (0.40 g, 0.35 mmol, 0.35 equiv.)), p-anisidine (0.135, 1.1 mmol, 1.1 equiv.) and 
Isobutyraldehyde (0.091 mL, 1 mmol) were dissolved in DMSO/acetone (4:1, 10 mL). The 
reaction was stirred at room temperature overnight or until the starting material was consumed 
as indicated by TLC. The mixture was extracted with phosphate-buffered saline (PBS) solution 
(pH 7.4) and ethyl acetate. The organic layer was dried with MgSO4, filtered, the solvent 
removed under reduced pressure and the residue purified by column chromatography with (2:1 
light petroleum  ether/ ethyl acetate), giving the title compound as a colourless oil (0.114 g, 
48%). 
 
ν
max 
(CH2Cl2)/cm
-1
 3363, 2957, 2832, 1707, 1511, 1465, 1237, 1036, 822; 1H NMR (500 MHz, 
CDCl3) δ 6.78 – 6.73 (m, 2H), 6.61 – 6.54 (m, 2H), 3.73 (s, 3H), 3.65 (dd, J = 12.3, 5.4 Hz, 
1H), 2.55 (qd, J = 16.0, 6.2 Hz, 2H), 2.14 (s, 3H), 1.97 – 1.88 (m, 1H), 0.96 (d, J = 6.9 Hz, 3H), 
0.90 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 208.4, 152.1, 141.6, 115.0, 56.2, 55.8, 
45.2, 31.2, 30.6, 18.7, 18.4. 
 
 
 
 
 
 
 
 
 
139 
 
 
(4S)-4-(4-Bromophenyl)-4-[(4-methoxyphenyl)amino]-2-butanone 
 
 
 
L-proline (0.40 g, 0.35 mmol, 0.35 equiv.)), p-anisidine (0.135, 1.1 mmol, 1.1 equiv.) and 4-
Bromobenzaldehyde (0.185 g, 1 mmol) were dissolved in DMSO/acetone (4:1, 10 mL). The 
reaction was stirred at room temperature overnight or until the starting material was consumed 
as indicated by TLC. The mixture was extracted with phosphate-buffered saline (PBS) solution 
(pH 7.4) and ethyl acetate. The organic layer was dried with MgSO4, filtered, the solvent 
removed under reduced pressure and the residue purified by column chromatography with (2:1 
light petroleum  ether/ ethyl acetate), giving the title compound as a colourless solid (0.254 g, 
72%). 
ν
max 
(CH2Cl2)/cm
-1
 3373, 2955, 2833, 1710, 1510, 1402, 1238, 1034, 815, 527; 1H NMR (500 
MHz, CDCl3) δ 7.45 – 7.40 (m, 2H), 7.25 – 7.20 (m, 2H), 6.71 – 6.66 (m, 2H), 6.47 (d, J = 8.3 
Hz, 2H), 4.71 (t, J = 5.6 Hz, 1H), 3.69 (s, 3H), 2.88 (d, J = 6.5 Hz, 2H), 2.11 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 206.8, 131.8, 128.1, 121.0, 115.4, 114.7, 60.4, 55.6, 54.7, 51.1, 30.7, 21.0, 
14.2. 
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(4S)-4-(4-Fluorophenyl)-4-[(4-methoxyphenyl)amino]-2-butanone 
 
 
L-proline (0.40 g, 0.35 mmol, 0.35 equiv.)), p-anisidine (0.135, 1.1 mmol, 1.1 equiv.) and 4-
fluorobenzaldehyde (0.124 g, 1 mmol) were dissolved in DMSO/acetone (4:1, 10 mL). The 
reaction was stirred at room temperature overnight or until the starting material was consumed 
as indicated by TLC. The mixture was extracted with phosphate-buffered saline (PBS) solution 
(pH 7.4) and ethyl acetate. The organic layer was dried with MgSO4, filtered, the solvent 
removed under reduced pressure and the residue purified by column chromatography with (2:1 
light petroleum  ether/ ethyl acetate), giving the title compound as a orange oil (0.071 g, 24%). 
ν
max 
(CH2Cl2)/cm
-1
 3381, 2999, 2833, 1711, 1509, 1359, 1237, 1036, 820, 537; 1H NMR (500 
MHz, CDCl3) δ 7.35 – 7.29 (m, 2H), 7.03 – 6.98 (m, 2H), 6.71 – 6.67 (m, 2H), 6.52 – 6.46 (m, 
2H), 4.74 (t, J = 6.5 Hz, 1H), 3.69 (s, 3H), 2.89 (d, J = 6.1 Hz, 2H), 2.11 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 207.0, 130.1, 127.9, 122.1, 116.4, 115.4, 114.8, 114.7, 55.6, 55.5, 54.6, 
52.5, 30.9, 30.7, 15.9. 
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Area % Report 
 
 
 
 
 
 
 
Data File: C:\EZChrom Elite\Data\nawaf\aldol\aldol testing\AT4\ATb4 (CO2H) (H2)  
Method: C:\EZChrom Elite\Data\nawaf\aldol con\92.8 0.8 220nm 25c.  
Acquired: 02/10/2017 16:19:45  
Printed: 17/01/2018 15:29:34  
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UV Results     
Retention Time Area Area % Height Height % 
26.810 860594 39.28 24606 40.72 
28.787 1330277 60.72 35814 59.28 
     
Totals     
 2190871 100.00 60420 100.00 
144 
 
 
Area % Report 
 
 
 
 
Data File: C:\EZChrom Elite\Data\nawaf\Mannich\mannich test\MT4\MT4a (OMe) 
Method: C:\EZChrom Elite\Data\nawaf\Mannich cond\90.10 0.6 ml 254 25c.met 
Acquired: 07/09/2017 13:21:07 
Printed: 07/09/2018 15:24:18 
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UV Results     
Retention Time Area Area % Height Height % 
11.613 1451709 27.53 53649 30.25 
14.613 3820702 72.47 123726 69.75 
     
Totals     
 5272411 100.00 177375 100.00 
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